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Abstract 
This thesis examines the hypothesis that coronary artery motion analysis is predictive of 
the location of clinical coronary artery events. It includes a preamble that describes a 
clinical scenario highlighting this unmet clinical need and describes in detail the 
components of this thesis. The thesis includes an overarching statement and a series of 
published and unpublished manuscripts.  
The published manuscripts describe in detail the findings that: 
1. Qualitative coronary artery motion analysis predicts the location of culprit lesions 
responsible for ST segment elevation myocardial infarctions (published prior to 
commencement of this doctoral degree). 
2. The pattern of qualitative coronary artery motion in patients with subsequent ST 
segment elevation myocardial infarction is not different to the pattern in 
angiographically normal coronary arteries. 
3. Two-dimensional quantitative coronary artery motion analysis predicts the 
location of future non-ST segment elevation myocardial infarctions. 
4. Quantitative coronary artery motion analysis using multislice computed 
tomography correlates with the location of coronary artery disease. 
The unpublished manuscripts describe in detail (that): 
5. Two-dimensional quantitative coronary artery motion analysis predicts the 
location of future ST segment elevation myocardial infarctions. 
6. A four-dimensional quantitative method for coronary artery motion analysis and 
its relationship to both the location of  
a. stenotic disease, and 
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b. lesion location in ST segment elevation myocardial infarctions. 
 
An important conclusion of this thesis is that coronary artery motion analysis has utility 
for the prediction of clinical coronary artery events, although further development and 
refinement of analysis methodology is required prior to its clinical application. 
  
 
 
 
5 
Preamble 
Sitting in a hospital catheterization laboratory in the middle of the night waiting for a 
patient to complete their transfer from an affiliated hospital for primary angioplasty 
allows a little time to think. After satiating the desire for caffeine, thoughts usually turn to 
the patient and procedure about to be performed.  
 
One such night, the information available was that the patient had inferior ST segment 
elevation (without the electrocardiogram being available for review) and had a diagnostic 
angiogram at the hospital three months previously. Review of the films showed focal 
non-obstructive plaques in both the left circumflex and right coronary arteries that were 
potential culprits.  
 
After a successful procedure for a completely occluded right coronary artery, discussion 
with the patient further clarified a number of interesting questions. Where in the coronary 
arteries was the culprit located? What was at this location on the prior diagnostic 
angiogram? Why was the heart attack not predicted following the diagnostic angiogram 
just three months before? Why was this heart attack not preventable?  
 
The short answer to these questions is that one of the limits of the current state of the art 
of interventional cardiology is that there is no current proven clinical strategy to predict 
and prevent a sequence of events such as that described above. Risk of this sequence of 
events can be reduced with lifestyle and medication interventions that this patient had 
been compliant with. No interventional devices have been shown to have favorable 
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efficacy and safety to prevent events such as these. 
 
Within a few months of these nocturnal ponderings, I was attending the annual Cardiac 
Society of Australia and New Zealand meeting listening to Professor Harvey White 
describe the five most novel local research articles published in the preceding year. One 
of these was by Professor Nicholas Bett and Tsuyoshi Konta[1]. It described a qualitative 
method for the analysis of coronary artery motion and showed a strong correlation 
between the compression type of coronary artery motion and the location of stenotic 
coronary artery disease. Applying this method of coronary artery motion analysis to the 
research question of identifying the location of subsequent culprit lesions responsible for 
myocardial infarctions appeared feasible. 
 
Using this qualitative method, I made the original finding (in work performed prior to 
enrolment for this degree) that this type of coronary artery movement is predictive of the 
location of the culprit lesion causing subsequent ST segment elevation myocardial 
infarction with a large odds ratio of 6.10 (p-value 0.005)[2]. This finding was 
independently reproduced in a much larger study by a group at a cardiology center of 
excellence elsewhere in Sydney[3].  
 
This finding led to the research question of whether the compression type of coronary 
artery motion was present more often in patients who had subsequent myocardial 
infarctions. This question was addressed in this thesis in a case-control study where the 
coronary artery motion patterns in patients who would subsequently have STEMI were 
compared with patients without any coronary artery disease detectable by angiography. 
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No difference was found between the two groups in the frequency of the compression 
type of motion. Interestingly, the compression type of motion in both groups was more 
frequent in the proximal and mid portions of the coronary arteries, theoretically matching 
the previously described asymmetrical distribution of the location of culprits causing 
myocardial infarctions[4].  
 
The qualitative method used to answer the two research questions described above had 
the limitations that it was both labor-intensive and open to potential observer bias. A 
quantitative method had the potential to address these limitations. A novel quantitative 
index of coronary artery motion derived from CT (computed tomography) coronary 
angiography that mirrored the compression type of coronary motion was described and 
shown to correlate with the location of coronary artery disease.   
 
A novel quantitative index of coronary artery motion derived from invasive coronary 
angiography was described and shown to be predictive of the location of future culprit 
locations in both STEMI and non-STEMI populations. This novel quantitative method 
was performed by analysis of individual imaging frames from invasive coronary 
angiography. These two-dimensional coronary images introduce known measurement 
errors including the foreshortening[5] and out of plane magnification[6] artifacts that 
have been well described.  
 
The next step to overcome these limitations was to use three-dimensional coronary 
reconstructions derived from coronary angiograms. This was performed with the two 
most widely available commercial software programs and preliminary results of this 
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research are included in the appendices. A strong sense of wanting to see “under the 
hood” of three-dimensional reconstruction software led to an ongoing collaboration with 
Dr Laurence Park and the development of prototype research software that has 
successfully reconstructed coronary arteries containing culprits for subsequent STEMI. 
 
This body of work makes the following original contributions: 
-using a previously described qualitative method to show that the patterns of coronary 
motion are the same in patients with subsequent STEMI and control patients with 
angiographically normal coronary arteries 
-describing for the first time a quantitative method for coronary artery motion analysis 
and showing it is predictive of the culprit location for subsequent STEMI and non-
STEMI 
-describing and using a quantitative method for coronary artery motion applied to three-
dimensional reconstructions of coronary arteries from both CT coronary angiography and 
conventional coronary angiography. 
 
This body of work provided a journey into the unknown that was challenging. Although 
my conclusion to date is that the methods described remain unsuited to clinical 
application, I remain excited by the possibility that this work may contribute in some 
small way to the potential evolution of the management of patients with coronary artery 
disease. 
 
Keywords: Coronary artery movement, Coronary artery disease, culprit lesion, 
Myocardial infarction, MSCT, Quantitative modeling  
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THESIS STRUCTURE 
The work presented in this thesis includes an introduction, a series of four papers (three 
of which are published in peer-reviewed journals and one has been submitted to a peer-
reviewed journal for publication), and appendices containing one previously published 
(prior to enrolment in this degree) and two unpublished draft manuscripts.  
The three published papers are: 
I. O'Loughlin A, Byth K, French JK, Richards DAB, Hennessy A, Denniss AR, 
Kovoor P. The compression type of coronary artery motion in patients with ST-
segment elevation acute myocardial infarction and normal controls: a case-
control study. BMC Research Notes 2011, 4(51) 
II. Aiden JC O’Loughlin, Linda Tang, Daniel Moses, Wisdom Tong, John K 
French, David AB Richards, Robert Denniss, Annemarie Hennessy. A Novel 
Quantitative Index of Coronary Artery Motion from Multislice Computed 
Tomography and the Location of Coronary Artery Disease. International 
Journal of Cardiovascular and Cerebrovascular Disease 2014 2(1):1 – 5. 
III. Aiden O’Loughlin, Samia Kazi, John K French, David AB Richards, A Robert 
Denniss, Annemarie Hennessy. Quantitative Coronary Artery Motion Analysis 
Predicts the Location of Future Non-ST Segment Elevation Myocardial 
Infarctions. Quantitative Coronary Artery Motion Analysis Predicts the 
Location of Future Non-ST Segment Elevation Myocardial Infarctions. 
International Journal of Cardiovascular and Cerebrovascular Disease 2014 
2(3):35 – 38. 
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The paper submitted for publication is: 
IV. Aiden O’Loughlin, Aaisha Ferkh, John K French, David AB Richards, A Robert 
Denniss, Annemarie Hennessy. Quantitative Coronary Artery Motion Analysis 
Predicts the Location of Future non ST Segment Elevation Myocardial 
Infarctions. Submitted to Physiological Measurement 
The published research (performed prior to enrolment for this degree) showing that 
qualitative coronary artery movement analysis is predictive of the culprit location of 
subsequent ST segment elevation myocardial infarction is included in Appendix 1: 
O’Loughlin A, Byth K. The stretch-compression type of coronary artery 
movement predicts the location of culprit lesions responsible for ST Segment 
Elevation Myocardial Infarctions. Heart Lung and Circulation. 16(4):266-268, 2007 
Aug. 
Further unpublished work undertaken as part of this thesis is included in Appendices 2 
and 3: 
Aiden O’Loughlin, Angelia Tjokrowidjaja, John K French, David AB Richards, A 
Robert Denniss, Annemarie Hennessy. A Novel Quantitative Index of Coronary 
Artery Motion from Four-Dimensional Coronary Angiography and the Location of 
Stenotic Coronary Artery Disease.  
Aiden O’Loughlin, Aaisha Ferkh, John K French, David AB Richards, A Robert 
Denniss, Annemarie Hennessy. The Relationship between Coronary Artery Motion 
and Lesion Location in ST segment Elevation Myocardial Infarction-Analysis 
Using 4-dimensional Quantitative Coronary Artery Motion Measurement.  
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1. Clinical Background 
 
Reducing the mortality and morbidity due to new and recurrent events from coronary 
artery disease is one of the largest and most important clinical needs in medicine. 
Coronary artery disease is the leading cause of death worldwide. It is the cause of death 
for 3.8 million men and 3.4 million women each year[7]. Of all patients who die within 
28 days of the onset of symptoms, two-thirds die before reaching hospital[7, 8].  
Death and disability due to coronary artery disease has been described in the medical 
literature for several centuries[9]. The PROSPECT (Providing Regional Observations to 
Study Predictors of Events in the Coronary Tree) trial[10] studied the contemporary 
natural history of patients following their presentation with acute coronary syndromes. 
The 3-year cumulative rate of recurrent major adverse cardiovascular events was 20%.  
In Australia, coronary heart disease death rates have been falling for several decades. 
From 1968 to 2006, the age-standardized death rate for coronary heart disease fell 76% 
(from 428.3 to 101.8 deaths per 100,000). Despite this dramatic reduction, coronary heart 
disease caused 17.1% of Australian deaths in 2006[11]. 
 
A similar reduction in coronary disease deaths has been seen in the United States. 
Between 1980 and 2000, the age-adjusted death rate for coronary heart disease fell from 
542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths 
per 100,000 population among women. The 47% decrease in the death rate was attributed 
to treatments, including secondary preventive therapies after myocardial infarction or 
revascularization (11%), initial treatments for acute myocardial infarction or unstable 
angina (10%), treatments for heart failure (9%), revascularization for chronic angina 
(5%), and other therapies (12%). Approximately 44% was attributed to changes in risk 
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factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), 
smoking prevalence (12%), and physical inactivity (5%), although these reductions were 
partially offset by increases in the body-mass index and the prevalence of diabetes, which 
accounted for an increased number of deaths (8% and 10%, respectively)[12]. 
 
The attribution of these dramatic improvements in death rates to reduction of risk factors, 
and treatment of clinical events and their sequelae show the benefits that can be gained 
from innovations in our understanding and treatment of coronary artery disease. 
 
1.1 Pathophysiology 
 
Most coronary artery disease is due to atherosclerosis. Atherosclerotic lesions are 
asymmetrical focal thickenings of the intima[13]. The first visible lesions are fatty 
streaks, an accumulation of lipid-laden cells below the endothelium[14]. Fatty streaks can 
progress to atheromas, which are comprised of a center of foam cells and extracellular 
lipid droplets surrounded by a cap of smooth-muscle cells and collagen-rich matrix. 
Some lesions consist mainly of fibrous connective tissue, whilst others are mainly 
calcified[15]. Complicated lesions have a luminal surface defect which provides a nidus 
for the formation of thrombus[16]. 
 
Atherosclerosis develops as a response to endothelial injury. This model was first put 
forward by Virchow in 1856 and was revised by Ross and Glomset[17-19]. The shear 
stress of coronary blood flow has been proposed as the cause of endothelial injury[20]. 
Abnormal shear stress has been proposed as the explanation for the asymmetrical 
distribution of culprit lesions in patients with acute myocardial infarctions, occurring 
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most commonly in the proximal and mid segments of all three coronary arteries (the left 
anterior descending, left circumflex and the right coronary arteries). These locations have 
been termed spatial high risk segments[4, 21]. Local biomechanical injury due to 
coronary artery motion represents a possible alternative cause of injury. The absence of 
atherosclerosis from relatively immobile arteries such as the internal mammary arteries 
may reflect an absence of biomechanical injury[22].  
 
In an examination of 400 cases of sudden coronary death published over a 15 year 
period[23], the frequency of coronary thrombus was 60%. The underlying etiology in 55 
to 60% was plaque rupture, 30 to 35% plaque erosion and 2 to 7% calcified nodule. In the 
40% of sudden coronary death patients where no acute thrombi were identified, healed 
infarctions and total occlusions are seen in the vast majority[23] and it is assumed that 
they die from arrhythmias[24]. To put this into context, in a study of the cause of sudden 
cardiac death over the age of 35 using national US mortality data from 1989 to 1998 [25], 
ischemic heart disease was the underlying cause in 62.2%, unspecified cardiovascular 
disease in 12.1% and cardiomyopathy/dysrhythmia in 9.3%. In turn, sudden cardiac death 
accounted for 63.9% of all cardiac deaths. Sudden cardiac death rates increase 
exponentially with age, rising from 34.1 per 100,000 men and 11.5 per 100,000 women 
aged 35 to 44 to 4073.3 per 100,000 men and 4171.8 per 100,000 women aged 85 years 
or over. Sudden cardiac death is the leading cause of death due to cardiovascular disease 
in the US, resulting in more than 300,000 deaths per year[26]. 
 
The physiological changes associated with unusual psychological stress, hypertension 
and a rise in catecholamine levels have been shown to be triggers for myocardial 
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infarctions[27, 28]. In a study of US firefighters[29], as compared to the odds of death 
during nonemergency duties, the odds of death from coronary heart disease were 12.1 to 
136 times as high during fire suppression, 2.8 to 14.1 times as high during alarm 
response, 2.2 to 10.5 times as high during alarm return, and 2.9 to 6.6 times as high 
during physical training. During the 2006 Federation Internationale de Football (FIFA) 
world cup in Germany, the incidence of cardiac emergencies in the greater Munich area 
on days of matches involving the German team was 2.66 times that during the control 
period (p<0.001)[30]. This was due to an increase in STEMI of 2.49 (95% CI, 1.47-4.23), 
non-STEMI of 2.61 (95% CI, 2.22-3.08), and cardiac arrhythmia of 3.07 (95% CI, 2.32-
4.06). The earthquake that struck Los Angeles on January 17, 1994 at 4:31 a.m. was 
associated with an increase in sudden cardiac death related to atherosclerotic 
cardiovascular disease from a daily average of 4.6(+/-2.1) in the preceding week to 24 on 
the day of the earthquake (p<0.001). Of the 24 deaths, 16 either died or had premonitory 
symptoms within the first hour after the initial tremor. Interestingly, during the six days 
after the earthquake, the number of sudden deaths declined to below the base-line value, 
to an average of 2.7(+/-1.2) per day[26].  
 
The chronobiology of sudden cardiac death has been described in a number of studies[31-
33]. The data show a circadian variation in the rate of sudden cardiac death, with a low 
incidence in the night and a peak incidence from 7 to 9 a.m. Risk of sudden cardiac death 
was at least 70% higher during the peak period than was the average risk during the other 
times of the day[33]. Perhaps not surprisingly, there is a very similar pattern in the 
circadian variation of nonfatal myocardial infarction and episodes of myocardial 
ischemia[32, 34].  
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Pathophysiological processes hypothesized to explain these observations include platelet 
activation[32], a  prothrombotic state[32, 34], elevations in heart rate and blood pressure, 
reduced electrical stability, and endothelial dysfunction-that, in the presence of a 
vulnerable atherosclerotic plaque, cause plaque disruption and thrombosis[35]. 
In animal studies, administration of vasopressors significantly increase coronary artery 
motion parameters such as distance moved, maximum velocity, acceleration and 
deceleration[36]. Whether the biomechanical stress of increased coronary artery motion 
triggers plaque rupture causing myocardial infarction remains an interesting but untested 
hypothesis. 
 
It is interesting to speculate on the mechanism by which coronary artery motion might 
contribute to the development and rupture of atherosclerotic plaques. The arterial wall 
has three layers. There may be differential compliance of the three layers to the 
mechanical stress of the stretch-compression type of coronary motion that may cause 
injury in those sections. In susceptible patients, the response to injury may lead to the 
development of atherosclerosis. This type of coronary artery motion might also lead to 
intimal tears and erosions at the time of plaque rupture and plaque erosion events. Intimal 
tears and erosions play a key role in the pathophysiological cascade leading to clinical 
coronary events. The amplitude of coronary artery motion may be increased in situations 
such as episodes of anger which have been shown to increase the risk of heart attack by 
over eight times in the subsequent two hours.[37]. Higher amplitude coronary artery 
motion may be a key mechanism for plaque rupture and erosion. Cardiac position and 
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rotation due to the respiratory cycle could also be speculated to play a role in these 
mechanisms. 
 
From a clinical perspective, better understanding of the pathophysiology of triggering of 
these events may provide means of prevention, particularly given the recent proof-of-
concept of the feasibility of provision of ad hoc therapy (in the form of aspirin or 
propranolol) at times of increased risk of triggering[38]. 
2. Predicting clinical coronary artery events in individuals 
 
Assessing individual patient risk of coronary artery disease events identifies the 
following patient groups as very high risk: established cardiovascular disease, diabetes 
mellitus[39], smoking, family history of premature coronary disease, hypertension, 
chronic kidney disease, and dyslipidemias.  
 
Some persons without established coronary heart disease (CHD) will have an absolute, 
10-year risk for developing major coronary events (myocardial infarction and coronary 
death) equal to that of persons with CHD, i.e. >20 percent. They can be said to have a 
CHD risk equivalent. The Third Report of the National Cholesterol Education Program 
(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults (Adult Treatment Panel III)[40] identified three such groups: 
patients with clinical atherosclerotic disease at other sites, patients with diabetes mellitus, 
and asymptomatic patients with multiple other risk factors who have an absolute, 10-year 
risk as high as that of persons with established CHD. 
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At the other end of the risk spectrum, patients without major risk factors for coronary 
artery disease have significantly lower relative risks of coronary heart disease mortality 
than those with risk factors (see Table 1).  
 
 
Table 1. Mortality from Coronary Heart Disease and All Cardiovascular Diseases for 
Low-Risk Subcohorts and Others (Reproduced from Stamler et al.[41]) 
 
This translated into significantly greater life expectancy[41]. However, less than 10% of 
the cohorts enrolled in the Multiple Risk Factor Intervention (MRFIT)[42] and Chicago 
Heart Association Detection Project in Industry (CHA)[43] trials were in this low risk 
category. 
Table 3. Mortality From Coronary Heart Disease and All Cardiovascular Diseases for Low-Risk 
Subcohorts and Others*.
Stamler, J. et al. JAMA 1999;282:2012-2018
Copyright restrictions may apply.
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Multivariate risk profiling has been used extensively for estimated coronary artery 
disease and cardiovascular disease in asymptomatic individuals. A number of tools have 
been developed, including the Framingham risk scores[40, 44, 45], the SCORE (Systemic 
COronary Risk Evaluation)[46], the QRISK2[47] and the Reynolds risk score[48]. These 
tools allow estimation of predictive risk of coronary and/or cardiovascular events on the 
basis of baseline risk factors.   
 
2.1 Intravascular Ultrasound and Angiography 
 
The largest contemporary trial to assess currently available technologies in the 
catheterization laboratory for the prediction of the location of future coronary events is 
the PROSPECT trial[10]. The PROSPECT trial was a multicenter trial conducted at 37 
sites in the United States and Europe. Six hundred and ninety seven patients with acute 
coronary syndromes were enrolled after successful percutaneous coronary intervention 
for their culprit lesion. Coronary angiography and gray-scale and radiofrequency 
intravascular ultrasound of the left main coronary artery and the proximal 6 to 8 
centimeters of each of the major epicardial coronary arteries were performed.  
Radiofrequency intravascular ultrasonography provides information about tissue 
composition that has been correlated with data from histological samples. 11 patients had 
complications during image acquisition. There were 10 dissections and 1 perforation 
resulting in 3 nonfatal myocardial infarctions.  
 
During a median follow-up of 3.4 years, there were 149 major adverse cardiovascular 
events in 135 patients (See Table 2)[10]. This represents an event rate of over 20%, 
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almost equally divided between events related to culprit lesions (118 lesions in 83 
patients) and events related to non-culprit lesions (104 lesions in 74 patients). Culprit 
lesion events were due to stent thrombosis (13), restenosis (107) and new stent-related 
side-branch lesions (5).  
 
 
Table 2. Kaplan-Meier Estimates for Cumulative Rates of Major Adverse Cardiovascular 
Events at 3 Years (reproduced from Stone et al.[10]) 
 
Angiographic data was not predictive of the location of non-culprit events. The mean 
angiographic diameter stenosis of the 106 non-culprit lesions was 32.3+/-20.6% at 
baseline. Thirty percent of lesions had a less than 30% stenosis, 37% had a 30-50% 
stenosis, 28% had a 50 to 70% stenosis and 5% had a greater than 70% stenosis. The 
most powerful baseline patient level independent predictors of non-culprit lesion events 
were insulin-requiring diabetes (HR (hazard ratio) 3.32, p=0.005), and previous 
percutaneous coronary intervention (HR 2.03, p=0.02).   
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A lesion on intravascular ultrasound (IVUS) was defined as at least three consecutive 
frames with a plaque burden of at least 40%[10]. No events arose from untreated 
segments with a plaque burden resulting in less than 40% loss of cross-sectional luminal 
area. 
 
Grayscale IVUS measurements were performed in 55 of the 106 non-culprit lesions. The 
minimum lumen area (MLA) was <5.9mm2 in 48 (87%) of the lesions and <=4.0mm2 in 
30 (55%) of the lesions. 48 (87%) of the lesions had a plaque burden of >=56%. Twenty 
five (45%) of the lesions had a plaque burden of >=70%. Forty five (82%) of the lesions 
had a length of >=11.2mm.  
 
Radiofrequency IVUS measurements were performed in 51 of the 106 non-culprit 
lesions. The dense calcium area was >=0.2mm2 in 34 (67%) of the lesions. The necrotic 
core area was >= 0.4mm2 in 34 (67%) of the lesions. The fibrous tissue area was <75% 
in 33 (65%) of the lesions. The fibrofatty area was <22% in 33 (67%) of the lesions. 
Lesions were classified (see Figure 1) as thin-cap fibroatheroma, thick-cap 
fibroatheroma, fibrotic, fibrocalcific and pathologic intimal thickening. In lesions with 
multiple patterns, the most severe pattern (in the order of the classification given above) 
was selected. Twenty six (51%) of the 51 lesions were thin-cap fibroatheromas. Eighteen 
(33%) of the lesions were thick-cap fibroatheromas. Six (12%) of the lesions were 
pathological intimal thickening and 1 was a fibrocalcific plaque. There were no lesions 
classified as fibrotic plaques.  
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Figure 1. Lesion classification according to radiofrequency IVUS (reproduced from 
Stone et al.[10]) 
 
Fibroatheromas (FA) were defined by the presence of >10% confluent necrotic core (NC; 
red color). If more than 30 degrees of the NC abutted the lumen in 3 or more consecutive 
frames, the fibroatheroma was classified as a thin-cap fibroatheroma (TCFA); otherwise 
it was categorized as a thick-cap fibroatheroma (ThCFA). Fibrotic plaque was defined as 
consisting mainly of fibrous tissue (FT; dark green color) with <10% confluent NC, 
<10% confluent dense calcium (DC; white color), and <15% of fibrofatty (FF; light green 
color). Fibrocalcific plaque was defined as mainly FT with >10% of confluent DC, with 
<10% of confluent NC. Pathological intimal thickening (PIT) was defined as ≥15% FF, 
with <10% confluent NC and <10% confluent DC. In addition, fibroatheromas were sub-
classified as having single or multiple confluent NCs and containing or not containing 
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DC. The entire lesion was evaluated for lesion level radiofrequency-IVUS classification. 
Multiple lesion subtypes were considered as separate lesions if they were separated by ≥ 
3 consecutive image slices of different morphology; for example, multiple TCFAs were 
considered separate if they were separated by ≥3 consecutive non-TCFA containing 
image slices.  
 
The most powerful baseline lesion level predictors of non-culprit lesion events were the 
following three variables: a plaque burden of 70% or more (HR 5.03, p<0.001), thin-cap 
fibroatheroma (HR 3.35, p<0.001), and MLA of 4.0mm2 or less (HR 3.21, p=0.001). 
Events occurred from lesions that included 0,1,2, or all 3 of these variables in 0.3%, 
4.8%, 10.5% and 18.2% of lesions, respectively (see Figure 2).  
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Figure 2. Event Rates for Lesions That Were and Those That Were Not Thin-Cap 
Fibroatheromas, at a Median Follow-up of 3.4 Years. Event rates associated with 595 
nonculprit lesions that were characterized as thin-cap fibroatheromas (TCFA) and 2114 
that were not by means of radiofrequency intravascular ultrasonographic imaging are 
shown according to minimal luminal area (MLA) and plaque burden (PB) as detected on 
gray-scale intravascular ultrasonography. The inset shows an example of a thin-cap 
fibroatheroma imaged as radiofrequency ultrasonography. Data on prevalence are for one 
or more such lesions per patient. Lesions in patients with indeterminate events were 
excluded (reproduced from Stone et al.[10]). 
 
Two thousand seven hundred and nine lesions overall were given a lesion classification 
based on radiofrequency IVUS. Five hundred and ninety five were classified as thin-cap 
fibroatheromas.  
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The authors of the PROSPECT trial concluded that the methods that they used for the 
detection of vulnerable plaque are not currently suitable for clinical application. All of the 
measures used had low specificity. As shown in figure 2, the event rate was only 18.2% 
when the three most predictive IVUS measures were combined. The C-statistic for 3 
multivariate models using these three measures was in the range from 0.82-0.84. The 
IVUS catheters used cannot be used to evaluate the distal portions of the coronary 
arteries. Thus, only 51 of the 106 non-culprit lesions were seen on radiofrequency 
intravascular ultrasonography. There were adverse events during IVUS imaging.  
 
The dynamic nature of coronary artery lesion morphology needs to be considered when 
interpreting the results of the PROSPECT trial. In a study[49] utilizing the same 
radiofrequency IVUS measurements as had been used in the PROSPECT trial, 99 
patients underwent serial radiofrequency IVUS evaluation at a median of 12 months. The 
changes in lesion characteristics are shown in Figure 3. 
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Figure 3. Changes in Plaque Characteristics Assessed by VH-IVUS Between Baseline 
and Follow-Up (reproduced from Kubo et al.[49]) 
 
At baseline, 20 thin-cap fibroatheromas were identified. On repeat study, 15 (75%) had 
healed and evolved into a different lesion type. 13 became thick-cap fibroatheromas, and 
2 became fibrotic. 12 new thin-cap fibroatheromas developed. At baseline, 6 were 
pathological intimal thickening and 6 were thick-cap fibroatheroma. 
The Synergy between PCI (Percutaneous Coronary Intervention) with Taxus and Cardiac 
Surgery (SYNTAX) score (SXscore) is an angiographic grading tool used to determine 
pre-PCI complexity of coronary artery disease[50]. The SXscore was calculated 
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prospectively in 2033 of the 2,292 patients enrolled in the RESOLUTE All Comers study 
(RESOLUTE III All Comers Trial: A Randomized Comparison of a Zotarolimus-Eluting 
Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). At 12 
months, rates of myocardial infarction were significantly higher in patients with the 
highest SXscore tertile[51]. The SXscore was calculated retrospectively in 807 patients 
enrolled in the randomized STRATEGY (Single High-Dose Bolus Tirofiban and 
Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial 
Infarction) and MULTISTRATEGY (Multicenter Evaluation of Sin-gle High-Dose Bolus 
Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute 
Myocardial Infarction Study) clinical trials. At 12 months, re-infarction was significantly 
higher in in patients with the highest SXscore tertile[52]. Similar results were found in 
2,627 patients undergoing percutaneous coronary intervention in the ACUITY (Acute 
Catheterization and Urgent Intervention Triage StrategY) trial[53]. 
2.2 Stenosis 
 
The summary of the results of six studies that evaluated the relationship between 
angiographic lesion stenosis severity and subsequent myocardial infarction[54-59] have 
previously been published[59]. This summary is shown in Table 3: 
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Study Location/Study 
Period 
Groups 
 
Baseline Lesion 
Percent Stenosis in 
Groups 
 
Interval (months) in 
Groups 
 
Time 
Analysis 
Performed 
Zaman et al USA/2003–2010 STEMI 
(41) 
NSTEMI 
(84) 
40 ± 24 45 ± 17 24 ± 19 28 ± 20 + 
Ambrose et al USA/∼1987 QWMI 
(15) 
NQWMI 
(8) 
34⁎ 80⁎ 18 (1–
84) 
33 (3–108) 0 
Decanay et al USA/1980–1991 QWMI 
(32) 
NQWMI 
(38) 
44 ± 25 23 ± 35 40 ± 28 44 ± 30 + 
Little et al USA/1975–1985 AMI (29) 44 ± 15 23 ± 23 0 
Giroud et al Switzerland/1972
–1990 
AMI (92) † 22 (1–94) + 
Hackett et al UK/1978–1985 AMI (10) 30 ± 15 23 (2–59) 0 
Values are presented as mean ± SD or median (range). 
AMI = acute myocardial infarction; UK = United Kingdom; USA = United States of America. 
 
⁎ SD not mentioned in the study. 
† Mean percent stenosis at baseline was not reported. Baseline stenosis in this study was reported in a categorical fashion. 
Table 3. Previous Angiographic Stenosis Studies 
 
The most commonly proposed explanation for the finding that most myocardial 
infarctions occur at locations where there was previously non-obstructive coronary artery 
disease is that myocardial infarctions occur most commonly after plaque rupture events, 
and the clinical sequelae reflects thin-capped fibroatheroma, rupture area, lipid content, 
and platelet and clotting mechanism which result in vessel occlusion irrespective of 
preceding degree of stenosis. 
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2.3 Restenosis 
  
Restenosis following percutaneous coronary intervention occurs due to neointimal tissue 
proliferation. A cascade mechanism involving platelets, polymorphonuclear leukocytes, 
and macrophage aggregation lead to medial smooth muscle cell migration and 
proliferation[60] with the development of neointima. Histopathological examples 
following balloon angioplasty are shown in Figure 4[61]. 
 
 
Figure 4. Histopathology of Restenosis. (l=lumen, m=media, ni=neointima; arrowheads 
show medial rupture zone) 
In a histological study of 55 stents from 32 patients[62], increased numbers of 
inflammatory cells were seen with stent struts in contact with damaged media (medial 
laceration or rupture) or lipid core (see Figure 5).  
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Figure 5. Inflammatory cell infiltrates associated with stent struts were assessed in 
coronary arteries containing stents of three or less days’ duration. There were increased 
numbers of inflammatory cells associated with struts in contact with lipid core and 
damaged media compared with fibrous plaque (P<0.001). 
 
Late neointimal growth was significantly greater (p<0.001) for stent struts in contact with 
damaged media than with plaque or intact media (see Figure 6). 
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Figure 6. In stents implanted for more than 30 days, neointimal thickness was increased 
at stent strut sites when medial laceration or rupture was present compared with struts in 
contact with plaque or with an intact media. 
 
A number of risk factors have been identified for stent restenosis. In a combined analysis 
of six bare metal stent trials[8], smaller pre-treatment minimum lumen diameter (MLD) 
and reference diameter, smaller final MLD, longer lesion length and stent length, diabetes 
mellitus, unstable angina, and hypertension were independent predictors of target lesion 
revascularisation (TLR) (see Table 4). TLR was defined as any repeat percutaneous 
revascularization or surgical bypass of the original target lesion site that occurred 30 or 
more days after the index procedure and was driven by clinical findings (presence of 
ischemic symptoms and/or a positive functional ischemia study), in the presence of a 
diameter stenosis greater than 50% as determined by the angiographic core laboratory.  
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Table 4. Independent Correlates of Target Lesion Revascularization 
Other risk factors that have been identified include ostial location of stenosis[63], in-stent 
restenosis[63], stent strut thickness with similar[64] or different[65] stent design, coil 
stent design[66], biomechanical problems and stent under-deployment[67]. 
 
The longitudinal straightening effect of stents has been identified as a powerful predictor 
of restenosis. In a study of 404 patients[68], vessel angulation of greater than or equal to 
33.5 degrees, a change in vessel angulation of greater than or equal to 9.1 degrees, and 
minimal lumen diameter (MLD) were all powerful independent predictors of major 
adverse cardiac events (see Table 5), which was comprised predominantly of restenosis. 
 
design or individual study. Of note, left anterior descending
artery lesion treatment and prior restenosis were not signif-
icantly associated with TLR after adjustment for these
covariates. The c statistic for the model was 0.68.
Repeat TLR and follow-up DS. The mean DS at the
time the CEC adjudicated TLR was 69.1 ! 11.9%. Figure
2 shows the cumulative frequency distribution of follow-up
DS for patients undergoing TLR. The DS was "60% for
only 22% of patients with adjudicated TLR, while 46% of
these patients had#70% DS. Unadjudicated TLR included
66 (14%) patients with "50% follow-up DS, of whom 49
had reported symptoms (27 with symptoms referable to
other disease who had incidental TLR, seven with TLR
during protocol follow-up angiogram, and 15 without
documented ischemia involving the target vessel and with
clearly documented DS "50% after review of quantitative
angiography).
Clinical restenosis relative to angiographic restenosis.
Angiographic follow-up was available for 1,437 (74%) of the
1,959 lesions assigned to routine angiographic follow-up
and was performed at 202 ! 44 days after the index
procedure. Angiographic restenosis was present in 419
(29.2%) lesions. Clinical restenosis rates (using adjudicated
or any reported event) for the patients with binary angio-
graphic restenosis are reported in Table 3, showing that only
about one-half of patients with angiographic restenosis
manifested clinical restenosis. Figure 3A displays the cumu-
lative distribution frequency of follow-up DS, and Figure
3B shows clinical restenosis rates relative to the severity of
angiographic restenosis for all patients with angiographic
binary restenosis. Nearly one-half of lesions that met criteria
for angiographic restenosis had follow-up DS "60%, and
only 22% had DS#70%. The likelihood for TLR correlated
directly with severity of angiographic restenosis, being
performed in only 26% of lesions with "60% DS.
Receiver operator characteristic curves of TLR relative to
Figure 1. Clinical restenosis rates as exemplified by target lesion revascularization (TLR), target vessel revascularization (TVR), or target vessel failure
(TVF) assessed at 6, 9, or 12 months. All events adjudicated by the Clinical Events Committee, and percentages determined by Kaplan-Meier method.
Solid bar $ TLR; striped bar $ TVR; open bar $ TVF.
Table 2. Independent Correlates of Target Lesion
Revascularization
Variables OR 95% CI
Final MLD (per mm)* 0.39 0.29–0.51
Reference diameter (per mm)* 0.48 0.40–0.59
Stent length (per 5 mm, per lesion)* 1.06 1.03–1.10
Lesion length (per 5 mm)* 1.11 1.04–1.17
Diabetes mellitus 1.49 1.16–1.92
Pretreatment MLD 0.66 0.49–0.88
Cigarette smoking (in past yr) 0.64 0.47–0.88
History of prior MI 0.70 0.54–0.90
Unstable angina 1.34 1.06–1.69
Hypertension 1.27 1.01–1.61
Variables listed in descending order of significance. *Colinear variable pairs (reference
diameter/final MLD and stent length/lesion length) were tested in separate multiva-
riable models. Other independent variables were not different between the two
models.
CI $ confidence interval; MI $ myocardial infarction; MLD $ minimal lumen
diameter; OR $ odds ratio.
2084 Cutlip et al. JACC Vol. 40, No. 12, 2002
Clinical Restenosis December 18, 2002:2082–9
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Table 5. Odds Ratio and 95% Confidence Intervals of Parameters Included in a 
Multivariate Nominal Regression Analysis for Predicting Major Adverse Cardiac Events 
3. Coronary Artery Motion Analysis 
  
Qualitative patterns of coronary artery motion (CAM) (see Figure 7) and a method to 
classify individual segments has previously been described[1].  
 
 
Figure 7. Patterns of Coronary Artery Motion (reproduced by Konta et al.[1]).  
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The Compression type of coronary artery motion incorporates the Compression and 
Ostial Compression patterns and correlates with the degree of stenosis within coronary 
artery segments[1]. The Compression type of coronary motion has been shown to be a 
powerful independent predictor of the location of culprit lesions in patients having future 
STEMI[2]. This finding was independent of the severity of stenosis and the location 
being in a spatial high-risk segment. This finding was confirmed in a larger sample with 
qualitative coronary artery motion analysis performed following fibrinolysis for 
STEMI[3].   
 
One key weakness of a qualitative method for assessing CAM is observer bias. Spatial 
high risk segments[4] and the association between stenosis and qualitative patterns of 
CAM[1] means there may have been a ready visual cue as to the possible location of the 
future culprit segment. Quantitative measures of CAM (such as that described for CT 
coronary angiography and illustrated in Figure 8) include change in vessel centerline 
length during the cardiac cycle may address this limitation.  
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Figure 8. Vessel reconstructions at two time points in the cardiac cycle. Landmarks for 
the left anterior descending and left circumflex coronary arteries are shown with 
matching colors in the reconstructions. Vessel centerline lengths for sections defined by 
these landmarks are used to calculate a quantitative measure of coronary artery motion. 
 
Other quantitative measures of coronary artery biomechanics previously described 
include centerline and point trajectory lengths, displacement amplitude, displacement 
direction, torsion, twist, spectrum and curvature[69-72].  
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4. CT coronary angiography 
 
 
Computed tomography (CT) coronary angiography technology has evolved rapidly in 
recent years and represents an alternative technology to invasive coronary angiography 
from which to derive measures of coronary artery motion. With the evolution of this CT 
coronary angiography have come improvements in the diagnostic accuracy for detection 
of coronary artery stenosis. In a 2008 meta-analysis of published data for 64-slice CT, the 
average patient-based detection of greater than or equal to 50% stenosis had a sensitivity 
of 98%, specificity of 88%, positive predictive value of 93% and a negative predictive 
value of 96%[73]. Similarly favorable diagnostic accuracy has been shown in single and 
multivendor multicenter trials[74-76]. This evolution has also resulted in the 
development of algorithms to optimize the image quality whilst minimizing the ionizing 
radiation dose administered to the patient. This has resulted in a change from 
predominantly retrospective studies where image data is acquired throughout the entire 
cardiac cycle to dose-modulated or prospective ‘step-and-shoot’ studies where image data 
is acquired predominantly from a pre-determined period within the cardiac cycle.  
 
Cardiac motion causes blurring and is the major reason for non-diagnostic coronary artery 
image quality[77]. Capturing image data during a phase of the cardiac cycle when the 
heart is relatively immobile minimizes blurring. At relatively low heart rates, the mid-
diastolic phase is well suited. At higher heart rates, the end-systolic phase may provide 
better image quality[78].  
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Whereas invasive coronary angiography provides imaging of contrast flow through the 
lumen of coronary arteries, CT coronary angiography also images the vessel wall. This 
allows measurement of plaque characteristics. In a study of 1,059 patients who underwent 
64-slice CT coronary angiography, 15 had subsequent acute coronary syndromes during a 
follow-up of up to 50 months.  Positive remodeling was defined as the diameter at the 
plaque site being at least 10% larger than the diameter in a more proximal normal-
appearing reference segment. Plaque consistency was defined as a low attenuation plaque 
if the Hounsfield units were less than 30. As show in Figure 9, acute coronary syndromes 
occurred in 10 of 45 (22.2% of) patients with plaque with both these features, 1 of 27 
(3.7%) patients with one of these features, and 4 of 820 (0.5%) of patients with neither of 
these features[79]. 
 
In a retrospective study of 458 patients who presented with low or intermediate risk acute 
chest pain who underwent first or second-generation dual source CT system, no patient 
without plaque had a major adverse cardiac event (MACE), such as myocardial 
infarction, revascularisation, cardiac death, or angina requiring hospitalization at a mean 
follow-up of 13 months[80]. By contrast, patients with four or more segments containing 
plaque had a hazard ratio of 151.77 compared to those with no plaque (p<0.001). 
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Figure 9. Acute Coronary Events in Patients on the Basis of Plaque Characteristics. Of 
the 45 patients showing 2-feature positive plaques, 10(22.2%) developed acute coronary 
syndrome (ACS), whereas 1 of the 27 patients with 1-feature positive plwques had ACS 
(3.7%) Only 4 (0.5%) of the 820 patients with 2-feature negative lesions had an acute 
event, and none of the 167 patients with normal arteries developed ACS. LAP = low-
attentuation plaque; PR = positive vessel remodeling (reproduced from Motoyama et 
al.[80]). 
 
A published comparison of the properties of invasive coronary angiography, CT coronary 
angiography, and intravascular ultrasound typical of those most commonly used in 
clinical practice in Australia are shown in Table 6[81]. 
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 CCA IVUS CCTA 
Spatial 
resolution 
200 µm 100–150 µm 350 µm 
Temporal 
resolution 
5–10 ms NA 40–100 ms 
Imaging Projection/2DLumen Cross-sectional 
Wall and lumen 
Cross-sectional 
Wall and lumen 
Parameter % Diameter stenosis Minimum 
luminal area 
Minimum 
luminal area 
Plaque 
character 
Not applicable Readily 
available 
Readily 
available 
Imaging 
area 
All segments Limited 
segments 
All segments 
Acquisition Invasive Highly invasive Noninvasive 
Radiation 5 mSv >5 mSv (part of 
PCI) 
2–20 mSv 
 
Table 6. Comparison of catheter coronary angiography, intravascular ultrasound, and 
coronary CT angiography 
5. Innovation 
 
 
Improved prediction of clinical events from coronary artery disease is a compelling 
clinical need. This introduction highlights the strengths and weaknesses of some key 
current technologies in meeting this need. The opportunity exists for innovation to 
improve prediction of events. This has the potential to lead to better utilization of current 
treatments and to provide inspiration for the development of novel treatments in the 
future.  
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6. Précis of the four publications 
 
6.1 Paper I 
 
The compression type of coronary artery motion in patients with ST segment 
elevation myocardial infarction and normal controls: a case-control study. 
 
This paper makes the original contribution of exploring whether coronary artery motion 
patterns are different in patients who have subsequent ST segment elevation myocardial 
infarction and controls with angiographically normal coronary arteries. No statistically 
significant difference was found for the frequency of CAM types between the two 
groups. Coronary artery motion reflects the motion of the underlying myocardium and 
the results of this study were interpreted that the motion of the underlying myocardium is 
not different between these two populations. This does not, however, lead to the 
conclusion that coronary artery motion is not useful for predicting the location of the 
culprit lesion responsible for future events in at risk patients. It does suggest that more 
than just these patterns of coronary artery motion are required. It also suggests that the 
specificity of coronary artery motion for the prediction of the location of culprit lesions 
may be imperfect.  
 
A specific focus in this paper was the Compression type of coronary artery motion. In 
work I performed and published prior to the period of PhD candidature (and included in 
Appendix 1), I have shown that this type of motion is a statistically significant 
independent predictor (odds ratio, 6.10, p-value 0.005) of the location of culprit lesions 
responsible for ST segment elevation myocardial infarction[2]. This odds ratio was 
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obtained by using a generalized linear mixed model with grouping by patient. The 
explanatory variables assessed were the type of CAM (with a binary classification as 
compression or non-compression types), stenosis, and high-risk segment. High-risk 
segments were defined as segments 1,2,9,10,17, and 19. These segments were selected to 
represent the known high-risk locations[4, 82] that make up the asymmetrical distribution 
of culprit lesions that have previously been shown to be responsible for ST segment 
elevation myocardial infarction. 
 
Using the qualitative classification of coronary artery motion (shown in both Figure 7 of 
the Introduction (p.33) and Figure 1 of Paper I) described by Konta and Bett[1], the 
frequency of the different patterns of coronary artery motion were assessed. Table 2 of 
Paper I shows the results of this analysis. Given the results of the study described in the 
last paragraph, the hypothesis being tested was whether there was a higher frequency of 
the compression type of coronary artery motion in patients having subsequent ST 
segment elevation myocardial infarction than in patients with angiographically normal 
coronary arteries. The compression type of coronary artery motion was present in 32.9% 
of segments of patients having STEMI and in 33.1% of segments of control patients. The 
proportion of the compression type of CAM for individual artery segments for both 
patient groups is shown in Figure 3 of Paper I. A Chi-squared test did not show a 
difference between the patient groups for the individual coronary artery segments 
(p=0.59).  
 
In an exploratory analysis included in Paper I, the distribution in coronary segments of 
the compression type of CAM was compared to the location of the culprit lesion 
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responsible for STEMI in 280 patients in a previously published report[4]. The results of 
this analysis are shown in Figure 4 of Paper I. The percent compression type of CAM and 
the percent of culprit lesions per centimeter of artery were highest for the proximal and 
mid parts of the right coronary artery (segments 1 and 2) and the proximal and mid parts 
of the left anterior descending coronary artery (segments 9 and 10). 
 
Paper I reported research showing no difference in the proportion of the compression 
type of coronary artery motion between the patients having STEMI and normal controls. 
A possible explanation for these findings is that systemic factors determine whether a 
patient develops coronary atherosclerosis and local biomechanical and/or haemodynamic 
shear stress determines its location within the coronary arteries. This explanation is in 
keeping with the response to injury hypothesis of Ross[18]. 
 
The qualitative methodology used in Paper I relied on a visual assessment of coronary 
artery motion from angiographic data. The previously well described high-risk segments 
and the presence of coronary plaque and stenosis provided ready visual clues to the 
researcher making the visual assessment. This limitation led to the research question of 
whether a quantitative method could be used to describe and explore the relationship 
between current and future coronary artery disease and clinical events. A novel 
contribution of this thesis is the description and use of a quantitative method for the 
evaluation of coronary artery motion as described in Paper II with CT coronary 
angiography data and in Papers III and IV with invasive coronary angiograms.  
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6.2 Paper II  
 
A novel quantitative index of coronary artery motion from multislice computed 
tomography and the location of coronary artery disease. 
 
Paper II reports the original contribution of a quantitative measure of compression type of 
coronary artery motion (QCAM) using CT coronary angiograms. This paper reports the 
finding that QCAM correlates with the location of coronary artery disease and stenosis.  
Coronary arteries were divided into sections using landmarks that could be identified at 
two time-points in the cardiac cycle representative of both end-diastole and end-systole 
(illustrated in both Figure 8 of the Introduction (p.34) and Figure 1 of Paper II). The 
quantitative index of coronary artery motion QCAM was defined as the percent 
shortening of centerline lengths between the time points (QCAM=100x(centerline length 
for section X at end-systole)/(centerline length for section X at end-diastole)%. 
QCAM was described for the first time in this paper and was found to be significantly 
less in coronary sections with plaque (94.3%+/-8.1%) than those without (99.0%+/-
10.2%) (p=0.023). There was a significant correlation between QCAM and plaque 
stenosis (Spearman’s rank correlation coefficient, ρ= -0.192, p=0.018). The correlation 
between QCAM and plaque type was not statistically significant (Spearman’s rank 
correlation coefficient, ρ= -0.156, p=0.057), but may be of clinical significance. 
This research was performed using CT coronary angiography studies that had been 
performed using a retrospectively gated protocol with acquisition of coronary images 
throughout the entire cardiac cycle. This type of acquisition protocol has become less 
frequently used with the evolution of coronary CT technology. Prospectively gated 
protocols are now much more commonly used. This often does not involve the 
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acquisition of data in the end-systolic phase of the cardiac cycle, precluding calculation 
of QCAM. Collection of CT data superfluous to that required for coronary image 
reconstruction causes an increased radiation dose to be administered. Therefore, it would 
currently not be ethical to undertake this approach for purely research purposes.  
 
CT coronary angiography and invasive coronary angiography are fundamentally different 
imaging modalities with specific strengths and weaknesses that greatly influence any 
comparison of respective coronary assessment. CT coronary angiography scan conditions 
are more important for the resolution of the images obtained. Higher heart rates (>65 
beats/min) and larger patients (body mass index >40) frequently lead to decreased image 
quality[83]. In phantom studies under ideal conditions, CT has the potential to quantify 
coronary stenoses at least as accurately as fluoroscopic angiography—with an advantage 
for lesions with noncircular geometry. This is not necessarily transferrable to the clinical 
setting due to reduced image resolution related to scan conditions[84]. Problems 
encountered clinically include more rapid heart rates, atrial fibrillation, and patient and 
coronary artery motion artifacts. Probably the greatest limitation for CT currently is its 
difficulty in visualizing the arterial lumen in the presence of severe coronary calcification 
due to the ‘blooming’ artifact. Analysis of the CorE-64 study showed that increasing 
coronary arterial segment calcification was associated with reduced diagnostic accuracy 
for detection of fifty percent or greater luminal stenoses[85].  
 
An understanding of these potential limitations led to the concomitant development of a 
novel quantitative method using invasive coronary angiograms that is described in Papers 
III and IV. 
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6.3 Papers III (published) and IV (submitted for publication) 
 
Quantitative coronary artery motion predicts the location of future ST segment 
elevation myocardial infarctions. 
and 
Quantitative coronary artery motion predicts the location of future non-ST segment 
elevation myocardial infarctions (submitted for publication). 
 
Paper III provides the original contribution of a quantitative measure of the compression 
type of coronary artery motion obtained from analysis of invasive coronary angiograms 
and shows that it can predict the location of culprit lesions in patients who have 
subsequent ST segment elevation myocardial infarction. Coronary angiography frames 
were selected at end-diastole and end-systole in two views for each culprit artery for each 
patient. The coronary arteries were divided into sections and the ratio of the section 
lengths from end-systole to end-diastole was used to calculated QCAM. This method is 
illustrated in Figure 1 of Paper III.  
 
In Paper III, QCAM was shown to be a statistically significant predictor of the location of 
culprit lesions responsible for future STEMI (p=0.0004 with t-test and p=0.026 with a 
generalized linear mixed model). This finding is reflected in the lower mean QCAM 
value for culprit sections (93.43) compared to non-culprit sections (103.51).  
Figure 2 of Paper III shows QCAM for each section for each of the two views for each 
patient. The data is consistent with the main finding of this paper. However, it shows a 
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large overlap between QCAM for culprit sections and a subgroup of the non-culprit 
sections.  
 
Paper IV (submitted for publication) makes the original contribution of extending the 
methodology of Paper III to a sample of invasive coronary angiograms of patients who 
have future non-STEMI. A statistically significant result was again shown for the 
relationship between QCAM and culprit sections, although the magnitude of the 
difference in the mean QCAM value for culprit sections (95.68) and non-culprit sections 
(98.16) was not as large as found in the sample of patients having STEMI. Figure 2 and 3 
of Paper IV again showed the overlap between QCAM for culprit sections and a 
subgroup of the non-culprit sections.  
 
This overlap represents the major limitation of this research’s potential clinical 
application. Possible explanations for this overlap are that these non-culprit sections are 
under the same biomechanical stress due to coronary artery motion as the culprit sections 
and could be potential culprit sections in the future. Alternatively, the overlap may be 
caused by measurement error introduced by the foreshortening artefact and out of plane 
magnification errors introduced by measuring a moving three-dimensional artery from a 
two dimensional image.  
To further evaluate this limitation, use was made of three-dimensional coronary artery 
reconstruction software to minimise these potential measurement errors.  
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7. Précis of Unpublished Research 
 
7.1 Appendix 2 
 
In unpublished data included in a draft manuscript Appendix 2, the quantitative method 
of coronary artery motion analysis was extended to four-dimensional coronary analysis in 
a pilot study. For a sample of patients undergoing elective PCI for unstable angina, 
commercially available three-dimensional artery reconstruction software was used to 
create three-dimensional artery section reconstructions at two time points (end-diastole 
and end-systole) in the cardiac cycle. A quantitative measure of the compression type of 
coronary artery motion derived from four-dimensional coronary angiography, QCAM4D, 
was defined and used to see if there was an association between this measurement and 
sections containing stenosis being treated by PCI. The mean QCAM4D was not 
statistically significantly different between coronary sections being treated for 
percutaneous coronary intervention (7.57%+/-5.96%) than those that were not 
(8.70%+/8.73%) (p=0.67).  
 
The result of this study was unexpected. The study was undertaken using a Leonardo 
workstation (IC3D, Siemens), which is derived from the Cardio-op B system (Paieon 
Medical, Rosh Ha'ayin, Israel). The system would not load historical angiograms (such as 
those used in Study design for Papers 1, 3 and 4) and a new population (patients with 
unstable angina undergoing elective coronary intervention) was sampled in this pilot 
study. It was originally considered that this might be the explanation for the unexpected 
finding, and the research direction shifted to the use of Cardiovascular Angiography 
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Analysis System (CAAS) Quantitative Coronary Angiography (QCA) 3-dimensional 
(3D) software (Pie Medical Imaging BV, The Netherlands). 
7.2 Appendix 3 
 
In unpublished data included in a draft manuscript Appendix 3, QCAM4D was evaluated 
as a predictor of the location of culprit lesion for a subsequent STEMI. In a trial design 
similar to both the published manuscript in Appendix 1 and Paper III, angiograms of 
patients who subsequently re-presented with STEMI were evaluated.  CAAS QCA 3D 
software was used to create three-dimensional artery section reconstructions at two 
timepoints (end-diastole and end-systole) in the cardiac cycle. QCAM4D was used to see 
if there was an association between this measurement and sections containing subsequent 
culprit lesions causing STEMI. A generalized linear mixed model did not find QCAM4D 
to be a statistically significant predictor of the locations of culprit lesions causing 
subsequent STEMI (p=0.32). 
 
This result was again unexpected. The CAAS QCA 3D software program loaded 
historical angiography data, and the study design replicated that previously used in 
Appendix 1 and Paper III. Although the findings of this study were negative, the 
distribution plot of culprit and non-culprit segments across QCAM4D (Figure 5 of the 
draft manuscript) did suggest the possibility of a similar signal to that found in the 
qualitative and earlier quantitative studies.  
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8 Ongoing Research and Future Directions  
 
 
To better understand the discrepancy between the qualitative/earlier quantitative and four 
dimensional study results, prototype four-dimensional reconstruction software was 
developed. This work was undertaken as collaborations initially with Professor Richard 
Hartley from the Australian National University and subsequently with Dr Laurence Park 
in the School of Mathematics and Computer Science, University of Western Sydney. 
Laurence and I jointly supervised Tanzila Chowdury, who undertook this work for an 
honours project.  
 
The algorithms for the current iteration of this software are as follows: 
1. Selection of end-diastolic and end-systolic frames from two coronary angiography 
views. 
2. Semi-automated edge detection of the coronary arteries 
3. Semi-automated centreline detection 
4. Sectional point correspondence detection across all 4 centrelines 
5. Centreline point correspondences 
6. 3 dimensional centreline reconstructions at end-diastole and end-systole using 
epipolar geometry and camera properties 
7. Calculation of centreline sectional lengths  
8. Calculation of QCAM4D for centreline sections 
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An example of a right coronary artery centreline reconstruction using the current iteration 
of the software is shown below: 
 
Future directions of research could involve developing this software further with specific 
tailoring to obtain quantitative measures of coronary artery motion and other quantitative 
measures of coronary physiology. Further software refinements could help clarify some 
of the discrepancies identified in the results of this thesis and potentially answer the 
question of whether quantitative coronary artery motion is useful in addressing the 
clinical need of predicting the location of future culprit events in patients with coronary 
artery disease. This hypothesis could be tested on large datasets - such as the dataset for 
the PROSPECT trial or its ongoing sequel, the PROSPECT II trial[86]. The PROSPECT 
II trial is enrolling 900 patients to examine two questions: whether coronary plaque 
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causing future clinical coronary events (vulnerable plaque) can be identified with 
intravascular ultrasound and near-infrared spectroscopy; and whether pre-emptive 
bioresorbable stenting of vulnerable plaque prevents myocardial infarctions. 
 
A collaborative research effort with Pie Medical Imaging, the Netherlands, is also 
underway, and will again address the discrepancy in the results to date. A Research 
Cooperation Agreement prevents disclosure of the details of this research at this time. 
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Abstract
Background: Prediction of the location of culprit lesions responsible for ST-segment elevation myocardial
infarctions may allow for prevention of these events. A retrospective analysis of coronary artery motion (CAM) was
performed on coronary angiograms of 20 patients who subsequently had ST-segment elevation myocardial
infarction treated by primary or rescue angioplasty and an equal number of age and sex matched controls with
normal angiograms.
Findings: There was no statistically significant difference between the frequency of CAM types of the ST-segment
elevation acute myocardial infarction and control patients (p = 0.97). The compression type of CAM is more
frequent in the proximal and mid segments of all three coronary arteries. No statistically significant difference was
found when the frequency of the compression type of CAM was compared between the ST-segment elevation
acute myocardial infarction and control patients for the individual coronary artery segments (p = 0.59).
Conclusion: The proportion of the compression type of coronary artery motion for individual artery segments is
not different between patients who have subsequent ST-segment elevation myocardial infarctions and normal
controls.
Introduction
The three-dimensional motion of the heart is character-
ized by rotation (around the centre of gravity), radial
displacement (towards or away from the center of grav-
ity), and translational motion (displacement parallel to
its long axis) [1]. The total translational motion of the
left ventricle is on average 2.2 cm and is such that
motion occurs most at the base and least at the apex of
the heart [2].
Motion of individual segments of coronary arteries
reflects the motion of the underlying myocardium. The
classification system for different patterns of coronary
artery motion (CAM) used in this study is derived from
a system where CAM was classified into 10 patterns,
which were grouped into 3 types: (1) compression type:
the length of the arterial segment is shortened without
vertical deviation of the artery; (2) displacement type:
the location of the coronary artery shifts without change
of the length or shape of the arterial segment; and
(3) bend type: the coronary artery flexes into a curve [3].
The compression type of CAM for individual artery
segments is associated with stenosis [3] and is a predic-
tor of segments containing the culprit lesion responsible
for ST-segment elevation myocardial infarctions (STE-
MIs) [4]. The compression type of CAM has recently
been shown to be strongly associated with segments
containing the culprit lesion in STEMI patients after
successful fibrinolysis [5].
The hypothesis to be tested in this study is that the
compression type of CAM is more likely to be present
in patients who have subsequent STEMI than in age* Correspondence: A.OLoughlin@uws.edu.au1University of Western Sydney, Sydney, Australia
Full list of author information is available at the end of the article
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and sex matched control patients with normal coronary
angiograms.
Methods
Twenty patients were identified who had coronary
angiography after March 1998 and subsequently re-
presented with a STEMI. STEMI was defined as
ischemic chest pain with ST segment elevation of 1 mm
in 2 contiguous limb leads or 2 mm in 2 contiguous
chest leads. Patients were excluded if they had previous
coronary artery bypass surgery or had stent thrombosis
as the cause of STEMI. Twenty age and sex matched
control patients were identified with normal coronary
angiograms.
The CAM patterns of coronary segments were
assessed retrospectively in both the STEMI and control
patients. For the STEMI patients, the coronary angiogra-
phy performed before the STEMI was used. The assess-
ment was made blinded to the location of the future
culprit segment. The CAM classification of Konta and
Bett [3] was used. A schematic of this classification is
shown in Figure 1. All three coronary arteries were
assessed using all available views. In a single view, a
visual comparison was made between the coronary seg-
ment at the start and end of systole. A single pattern of
motion was assigned in each view. Each segment was
then assigned a CAM pattern by synthesizing the
assignment for all available views. The patterns of CAM
were grouped into the compression type and non-
compression type (the bend and displacement types).
Assessment of CAM was made in up to fourteen seg-
ments of the coronary arterial tree. The segments were
given a numerical label as shown in Figure 2.
Clinical risk factors (hypertension, diabetes, smoking,
family history and hypercholesterolemia) of all patients
were obtained from the medical records.
Chi-squared tests were used for comparison of fre-
quencies between groups. All statistical analyses were
performed using Stata (version 10.0, StataCorp, College
Station, TX).
The Royal Prince Alfred Hospital Ethics Review Com-
mittee approved the research protocol (reference X10-
0159). The research protocol did not include obtaining
patient consent.
Results
The demographics for the STEMI and control patients
are shown in Table 1. The frequency of each pattern
and type of CAM for all the segments of both the
STEMI and control patients are shown in Table 2. 67%
of segments in both the STEMI and control patients
had a non-compression type of CAM. The bend type
was present in 44% of segments in the STEMI patients
and in 47% of segments in the control patients.
Figure 1 Classification of coronary artery motion. Lines illustrate the coronary artery segment and arrows show the direction of coronary
artery motion. C = compression, D = displacement.
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The displacement type was present in 23% of segments
in the STEMI patients and in 20% of segments in con-
trol patients. 33% of segments in both the STEMI and
control patients had the compression type of CAM.
There was no statistically significant difference between
the frequency of CAM types of the STEMI and control
patients (p = 0.97).
Figure 2 Coronary artery map. The figure shows the numerical labeling of segments of the coronary tree.
Table 1 Patient Demographics
STEMI
patients
Control
patients
Mean age (+/-stdev) 61 (+/-11) 61 (+/-12)
Men (%) 80 80
Diabetes (%) 25 25
Current smoker (%) 45 45
Hypercholesterolemia (%) 75 55
Hypertension (%) 55 50
Family history of coronary artery
disease (%)
25 35
Table 2 Frequency of each pattern and type of CAM
Pattern of CAM STEMI patients Control patients
Number (%) Number (%)
Non-compression 161 67.1 164 66.9
Bend 106 44.2 114 46.5
Bend 12 5.0 14 5.7
Multiple bend 77 32.1 89 36.3
Hinge 8 3.3 8 3.3
Crease 9 3.8 3 1.2
Wave flex 0 0 0 0
Displacement 55 22.9 50 20.4
Lever 0 0 0 0
Lineal displacement 31 12.9 13 5.3
Parallel displacement 24 10.0 37 15.1
Compression 79 32.9 81 33.1
Compression 71 29.6 65 26.5
Ostial compression 8 3.3 16 6.5
Total 240 245
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The proportion of the compression type of CAM for
individual artery segments for both patient groups is
shown in Figure 3. The compression type of CAM was
more frequent in the proximal and mid segments of the
right (#1 and 2), the left anterior descending (#9 and
10) and to a lesser extent the left circumflex (#17 and
19) coronary arteries. The compression type was less
frequent in the distal segments of the right (#3,4, and
5), left main (#8), distal left anterior descending (#11),
diagonal (#13), and the obtuse marginal branches (#18
and 20) of the left circumflex coronary arteries. No sta-
tistically significant difference was found when the fre-
quency of the compression type of CAM was compared
between the ST-segment elevation acute myocardial
infarction and control patients for the individual coron-
ary artery segments (p = 0.59).
Discussion
This study shows that the proportion of the compres-
sion type of coronary artery motion for individual artery
segments is not statistically significantly different
between patients who have subsequent STEMIs and age
and sex matched controls.
The main limitations of this study are its small sample
size and the potential observer bias in the qualitative
assessment of CAM. The technique relies on a visual
assessment. Knowledge of the asymmetrical frequency
distribution of culprit lesions in patients with STEMIs
[6] and the presence of stenosis within a segment may
bias the qualitative visual assessor.
Although the exact pattern of CAM varies amongst
individual patients, there are consistent themes of
motion differences between the different coronary
arteries [7,8] and along individual arteries [9]. The cor-
onary segments that had high proportions of the com-
pression type of CAM have previously been shown to
include the site of most STEMIs [6,10]. The distribution
in coronary segments of the compression type of CAM
for the 40 patients in this study and the location of the
culprit lesion responsible for STEMI in 280 patients in a
previously published report [6] are shown in Figure 4.
The percent compression type of CAM and the percent
of culprit lesions per cm of artery was highest for the
proximal and mid parts of the right coronary artery
(segments 1 and 2) and the proximal and mid parts of
the left anterior descending coronary artery (segments 9
and 10).
Previously published work has shown that the com-
pression type of CAM is a predictor of the location of
stenosis [3] and the culprit segment responsible for
STEMI [5,11]. This study builds on this work by finding
no difference in the proportion of the compression type
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Figure 3 Proportion of the compression type of CAM for individual artery segments. The segments in the proximal and mid portions of
the three coronary arteries had a high proportion of the compression type of CAM in both control and STEMI patients.
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of coronary artery motion between the STEMI popula-
tion and normal controls. A possible explanation for
these findings is that systemic factors determine whether
a patient develops coronary atherosclerosis and local
biomechanical and/or haemodynamic shear stress deter-
mines its location within the coronary arteries.
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Abstract  Background: We describe a novel quantitative 
index of coronary artery motion (QCAM) from multislice 
computed tomography (MSCT) and test its association with 
the location of coronary artery disease. Methods: 25 patients 
with known or suspected coronary artery disease underwent 
ECG-gated MSCT. The coronary artery images were divided 
into 150 sections using landmarks that could be identified at 
time points at end-diastole and end-systole. QCAM was 
derived from the change in centerline length of the coronary 
sections between these time points. Plaques were identified 
and classified by type and severity of stenosis. Results: The 
mean QCAM was significantly less in the coronary sections 
with plaque (94.3%+/-8.1%) than those without 
(99.0%+/-10.2%) (p=0.023). There was a significant 
correlation between QCAM and plaque stenosis 
(Spearman’s rank correlation coefficient, ρ= -0.192, 
p=0.018). The correlation between QCAM and plaque type 
approached statistical significance (Spearman’s rank 
correlation coefficient, ρ= -0.156, p=0.057). Sensitivity, 
specificity, positive and negative predictive values for the 
identification of coronary plaque within a section for QCAM 
<100% were 80%, 46%, 27% and 90% respectively. 
Conclusions: QCAM is a novel quantitative measurement of 
coronary artery motion that correlates with the location of 
coronary artery disease. Quantitative evaluation of coronary 
artery motion provides a new approach to understanding the 
biomechanics of coronary artery disease. 
Keywords  MSCT, Coronary Artery Disease, Coronary 
Motion, Quantitative Modeling 
 
1. Introduction 
The response to endothelial injury model of 
atherosclerosis was first proposed by Virchow in 1856 [1] 
and revised by Ross and Glomset in 1973 [2-4]. The shear 
stress of coronary blood flow is the mechanism of injury 
most commonly implicated [5-10]. Local biomechanical 
injury due to the axial strain of cyclical coronary artery 
motion has also been shown to be an alternative mechanism 
of injury [11]. Coronary artery motion has been proposed to 
have an effect on the location of coronary artery disease by 
causing both low shear wall stress and increased wall strain 
[12]. We and other authors have previously shown that the 
compression pattern of coronary artery motion correlates 
with the location of coronary artery disease [13] and is 
predictive of the locations of culprit lesions in STEMIs 
[14-16]. 
Multislice computerized tomography (MSCT) is one of 
the most exciting recent developments in cardiology. Rapid 
advances in technology have resulted in MSCT entering 
‘prime-time’ in recent years [17, 18]. Meta-analyses as early 
as 2007 support the potential use of 64 slice computed 
tomography coronary angiography in place of conventional 
coronary angiography (CCA) in carefully selected 
populations [19]. MSCT is superior to CCA alone in the 
analysis of plaque characteristics. Plaque characteristics 
have been shown to be different in patients with acute 
myocardial infarction or symptomatic stable angina pectoris 
[20] and to be predictive of future acute coronary syndromes 
[21]. MSCT readily allows quantitative evaluations to be 
performed. Coronary artery calcification is an example of a 
quantitative measurement that currently contributes 
significantly to risk stratification especially in persons with 
intermediate risk assessed by conventional risk analysis [22].  
2. Aim 
We describe a novel quantitative index of coronary artery 
motion (QCAM) obtained from MSCT. We test whether 
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there is an association between QCAM and the location of 
coronary artery disease. 
3. Methods 
3.1. Ethical Approval of the Study Protocol 
This study complied with the Declaration of Helsinki. The 
study was approved by the human research ethics committee 
of Royal Prince Alfred Hospital. 
3.2. Patients 
25 patients with known or suspected coronary artery 
disease who had undergone electrocardiographically-gated 
MSCT at Liverpool Hospital between April 2007 and 
January 2011 were evaluated. MSCT was performed using a 
retrospectively gated protocol on a 64 slice dual source 
cardiac CT scanner (SOMATON Definition, Siemens 
Healthcare). Patients were examined in a supine position, 
images extended from base of neck to the diaphragm during 
a single breath hold. Imaging parameters were as follows: 
detector collimation of 32×0.6 mm, slice acquisition 64×0.6 
mm by means of a z-flying focal spot, gantry rotation time 
330 ms, pitch of 0.2–0.43 adapted to the heart rate, tube 
current 400 mAs per rotation, and tube potential 120 kV. The 
patients were randomly retrospectively identified from a 
database of MSCT studies performed during this period. 
Clinical data of the patients and MSCT results was obtained 
from MSCT reports and medical records. 
 
Figure 1.  Vessel reconstructions at two time points in the cardiac cycle. 
Landmarks for the left anterior descending and left circumflex coronary 
arteries are shown with matching colors in the reconstructions 
3.3. Calculation of QCAM 
The images were reconstructed and manipulated on a 
dedicated cardiac work station. Raw data was reconstructed 
in 5% intervals throughout the cardiac cycle (which was 
defined as starting at the R wave). Vessel reconstructions 
that were representative of end-systole and end-diastole of 
the left ventricle were used for further analysis. The percent 
of the cardiac cycle for these two time points was recorded. 
The coronary arteries were divided into sections using 
landmarks that could be identified at both time points. Most 
landmarks were bifurcations. Figure 1 shows the concepts of 
vessel reconstructions at end-systole and end-diastole and 
landmarks. Centerline lengths from the ostium of the vessel 
to the identified landmarks were measured on curved 
multiplanar reconstructions. The centerline lengths for each 
section were derived (Section X = (Ostium to Landmark X) - 
(Ostium to Landmark (X-1)). QCAM was defined as the 
percent shortening of centerline lengths between the time 
points (QCAM=100x(centerline length for section X at 
end-systole)/(centerline length for section X at 
end-diastole)%. 
3.4. Plaque Stenosis and Plaque Type Evaluation 
Plaques within coronary sections were identified. Plaque 
stenoses were classified by the maximal luminal diameter 
stenosis seen on any plane and the severity of stenosis was 
graded as none, non-obstructive (<=50%) and significant 
(>50%). Plaque types were classified as calcified arterial 
plaques (CAP) when calcified tissue occupied >50% of the 
plaque area, plaques with <50% calcium as mixed calcified 
plaques (MCAP), and plaques without any calcium as 
non-calcified plaques (NCAP), as previously described [18].  
3.5. Statistical Analyses 
Statistical analyses were performed using Stata version 
8.0 (College Station, TX). Numerical values are expressed as 
mean and standard deviation unless otherwise stated. 
p-values <0.05 were considered statistically significant. The 
distributions of QCAM for sections with and without plaque 
were tested with an unpaired t test. Spearman’s rank 
correlation coefficients were calculated for QCAM and both 
plaque stenoses and plaque types. Receiver operating 
characteristics (ROC) analysis was used to test the 
relationship between sensitivity and specificity at different 
cutoff values of QCAM.  
4. Results 
4.1. Clinical and MSCT Characteristics of the Patients 
Baseline clinical characteristics of the patients are shown 
in Table 1. The age of the patients was 53.3(+/-15.6) years. 
16 (64%) of the patients were male. MSCT details are shown 
in Table 2. Chest pain was the indication for the majority of 
examinations. The elevated heart rate and high radiation 
doses reflect the selective use of retrospectively gated 
examinations in this study. 30 coronary plaques were 
identified in 11 patients. 4 patients underwent subsequent 
conventional coronary angiography (CCA). 2 of the patients 
had CCA within one week of their MSCT examinations. 1 of 
these patients was then referred for coronary artery bypass 
surgery. 1 was managed medically. 1 patient had CCA 6 
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months later with percutaneous treatment of a left anterior 
descending stenosis (in a section reported as non-diagnostic 
on the MSCT examination due to heavy calcification). 1 
patient had CCA 12 months later with only minor coronary 
disease identified. 
Table 1.  Baseline clinical characteristics 
Characteristic  
Age in years (+/-standard deviation) 53.3 (+/-15.6) 
Male sex, number (%) 16 (64%) 
Clinical information,  Number (%) 
Family history of premature coronary disease 5 (20%) 
Hypercholesterolemia 16 (64%) 
History of Smoking 7 (28%) 
Diabetes 8 (32%) 
Hypertension 14 (56%) 
Systolic blood pressure (mmHg) 138 (24%) 
Obesity 10 (40%) 
Table 2.  MSCT details 
Detail  
Indication,  Number 
Chest pain 19 
Cardiomyopathy 3 
Cardiac arrest 1 
Congenital heart disease 1 
Anomalous coronary artery 1 
Heart Rate in beats per minute (standard 
deviation) 74.9 (+/-13) 
Dose length product  (standard deviation) 734 (+/-300) 
Calcium scores Value (standard deviation) 
Agatston score 89.9 (+/-279) 
Volume score 71.4 (+/-225) 
Mass in mgCaHA 17.8 (+/-56) 
4.2. QCAM and Coronary Plaque 
Vessel reconstructions that were most representative of 
end-systole occurred at 37.1(+/- standard deviation of 5.1) % 
of the cardiac cycle. Vessel reconstructions that were most 
representative of end-diastole occurred at 73.2(+/1 standard 
deviation of 7.3) % of the cardiac cycle. Frequency 
distributions of QCAM for coronary sections without and 
with plaque are shown in Figure 2 with further categorization 
by plaque stenosis and plaque type in Table 3. QCAM was 
significantly less for coronary sections with plaque (94.3% 
+/-8.1%) than for those without plaque (98.9% +/-8.1%) 
(p=0.023). There was a significant correlation between 
QCAM and plaque stenosis (Spearman’s rank correlation 
coefficient, ρ= -0.192, p=0.018). The correlation between 
QCAM and plaque type approached statistical significance 
(Spearman’s rank correlation coefficient, ρ= -0.156, 
p=0.057). Sensitivity, specificity, positive and negative 
predictive values for the identification of coronary plaque 
within a section for QCAM <100% were 80%, 46%, 27% 
and 90% respectively. 
Table 3.  QCAM categorized by plaque stenosis and plaque type 
Categorization Sections  
QCAM (+/- 
standard 
deviation) 
P value 
 Number   
Plaque   0.023‡ 
None 122 99.0(+/-10.2)  
Present 30 94.3(+/-8.1)  
Plaque Stenosis   0.018† 
None 122 99.0(+/-10.2)  
NonObstructive 25 94.1(+/-7.4)  
Significant 5 95.2(+/-11.9)  
Plaque Type   0.057† 
None 122 99.0(+/-10.2)  
Non-calcified 10 95.1(+/-9.1)  
Mixed calcified 5 89.3(+/-9.6)  
Calcified 15 96.8(+/-7.9)  
‡Unpaired t test †spearman’s rank correlation 
 
Figure 2.  Frequency distribution of QCAM for coronary sections without 
and with plaque 
5. Discussion 
In this study, QCAM, a quantitative index of coronary 
motion from MSCT, is described for the first time. The mean 
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QCAM was 4.7% less in coronary sections with coronary 
plaque than in those without plaque. This difference was 
statistically significant. Interestingly, the point estimates for 
QCAM were similar for both non-obstructive plaque and for 
plaque that caused significant stenosis. In terms of plaque 
type, the point estimate for QCAM was smallest for mixed 
calcific plaque and similar for non-calcified and calcified 
plaque. The small number of sections with mixed calcific 
plaque and the wide confidence interval for the point 
estimates preclude any further interpretation of this 
observation. 
The frequency distribution of QCAM for coronary 
sections without and with coronary plaque (Figure 2) show 
considerable overlap of QCAM. In particular, a number of 
sections without plaque had QCAM values in the same range 
seen for sections with plaque. This is also reflected in the 
receiver operation characteristics of QCAM. Although the 
sensitivity (80%) and negative predictive value (90%) of a 
QCAM value of <100% for detection of coronary plaque 
within a section were excellent, the specificity (40%) and 
positive predictive value (27%) were disappointing. 
QCAM measures change in centerline length of a section 
of the coronary artery during the cardiac cycle. The decision 
to use this as a quantitative measure of coronary artery 
motion was based on the results of previous qualitative 
evaluations of coronary artery motion. In particular, change 
in centerline length was thought to best mirror the 
compression type of qualitative motion, which has 
previously been shown to correlate with the location of 
coronary artery disease [13]. The results in this study extend 
this finding to a quantitative method using MSCT. The 
compression pattern of coronary artery motion has also been 
shown to be predictive of the locations of culprit lesions in 
ST-segment elevation myocardial infarctions [14-16]. 
Whether QCAM is predictive of the location of culprit 
lesions in STEMIs is a clinically interesting hypothesis that 
remains to be tested. 
This study has a number of limitations. Firstly, the use of 
landmarks to calculate QCAM results in averaging of the 
index over the artery section. This averaged index was then 
correlated with the coronary plaque. Plaque location was 
often focal and not involving the entire section for which 
QCAM was correlated. Secondly, this study uses 
retrospectively ECG-gated MSCTs. The mean heart rate of 
the examinations was 75 beats per minute. Most MSCTs 
currently performed use prospective ECG-gating, with 
acquisition of data predominantly within a pre-specified 
window in diastole. This precludes the measurement of 
QCAM as described in this study. Clinical benefit of QCAM 
measurement is required before the use of extra radiation to 
acquire the additional data for its calculation would be 
warranted.  
6. Conclusion 
QCAM is a novel measure which correlates with the 
location of coronary artery disease. Quantitative evaluation 
of coronary artery motion using MSCT provides an 
opportunity to better understand the biomechanics of 
coronary artery disease. 
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Abstract  Background: Coronary artery motion may 
contribute to the development of plaques that rupture and 
cause acute myocardial infarctions. This study evaluates 
whether a quantitative measure of the compression type of 
coronary artery motion obtained from analysis of coronary 
angiograms can predict the location of culprit lesions in 
patients who have subsequent myocardial infarction. 
Method: 28 patients were identified with coronary 
angiography performed on at least two occasions: related to 
primary or rescue percutaneous coronary intervention for a 
STEMI and coronary angiography before this that was 
available for review. These angiograms were used to 
determine a quantitative index of coronary artery motion 
(QCAM) (the ratio of the section lengths i.e. systolic 
length/diastolic length). The culprit section was 
subsequently identified and QCAM of this section was 
compared to non-culprit sections. Results: The two sample 
t-test comparing QCAM for the non-culprit and culprit 
sections was highly statistically significant with a p-value of 
0.0004. The generalized linear mixed model with culprit 
section as the dependent variable and QCAM as the 
independent variable also showed a statistically significant 
result with a p-value of 0.026. Conclusion: QCAM is a 
predictor of the location of culprit lesions causing future ST 
segment elevation myocardial infarctions.  Predicting the 
location of future culprit lesions using coronary 
angiography may allow targeted therapy to prevent 
myocardial infarctions. 
Keywords  Coronary Artery Motion, Coronary Artery 
Disease, Myocardial Infarction 
 
1. Introduction 
Acute myocardial infarctions are usually caused by 
rupture of atherosclerotic plaques. Plaques form in the 
coronary arteries as a response to injury [1]. The location of 
plaques within the coronary arteries is asymmetrical [2], and 
their distribution is likely attributable to local biomechanical 
factors relating to fluid dynamics and wall mechanics. 
Coronary artery motion contributes to these biomechanical 
factors [3] and has been suggested to have an important role 
in the mechanisms of local injury [4]. 
Qualitative evaluation of coronary artery motion for artery 
segments has previously shown that the compression type of 
motion correlates with the location of disease and the degree 
of stenosis within coronary artery segments [5] and is 
independently predictive of the location of future culprit 
lesions responsible for ST segment elevation myocardial 
infarctions [6,7]. The compression type of coronary motion 
is defined as occurring when the length of the arterial 
segment is shortened without vertical deviation of the artery 
[5].  
These findings have been extended to a quantitative 
method using multislice computed tomography coronary 
angiography [8]. A significant correlation was found 
between a quantitative measure of vessel centerline 
shortening and the location of coronary plaque and the 
degree of stenosis. 
2. Objective 
This study aims to see if a quantitative measure of the 
compression type of coronary artery motion (QCAM) 
predicts the location of culprit lesions in patients who have 
subsequent ST segment elevation myocardial infarction. 
3. Methods 
 
   
 
3.1. Patients 
Patients were identified using the angiography databases 
at Westmead and Liverpool hospitals in Sydney with 
coronary angiography performed on at least two occasions: 
1. related to primary or rescue percutaneous coronary 
intervention for an STEMI; and  
2. coronary angiography before this that was available 
for review.  
STEMI was defined as chest pain characteristic of 
LVFKDHPLD ZLWK 67 VHJPHQW HOHYDWLRQ RI PP LQ WZR
FRQWLJXRXV OLPE OHDGV RU PP LQ WZR FRQWLJXRXV FKHVW
leads. Patients were excluded if they had previous coronary 
artery bypass surgery or acute stent thrombosis. The patients 
identified had coronary angiography at the hospitals between 
March 1998 and June 2010.  
3.2. Calculation of QCAM 
On the angiography performed prior to subsequent 
representation with acute myocardial infarction (2 above), all 
three of the main coronary arteries were examined in two 
angiographic views using ezDICOM, a digital imaging and 
communications in medicine software program [9]. Single 
frames were selected that best represented the coronary 
arteries at end-diastole and end-systole. End-diastole was 
defined as the largest cardiac silhouette within the cardiac 
cycle close to the peak of the R-wave in the ECG (when 
available), and end-systole was defined as the smallest 
silhouette close to the end of the T-wave. Each artery was 
divided into sections based on unique identifying points and 
corresponding points were identified in both angiographic 
views.  
The length of each section was measured from the single 
frames selected at end-diastole and end-systole using the 
software program Image J [10] as demonstrated in Figure 1. 
The quantitative measure of coronary artery motion (QCAM) 
was defined as the ratio of the section lengths i.e. systolic 
length/diastolic length.  
 
Figure 1, Part A.  Right Coronary Artery in Diastole from View 1 (Right 
anterior oblique 3.6°, Cranial 18.9°)  
 
Figure 1, Part B.  Right Coronary Artery in Systole from View 1 
 
Figure 1, Part C.  Right Coronary Artery in Diastole from View 2 (Right 
anterior oblique 28.9°, Caudal 1.2°) 
 
Figure 1, Part D.  Right Coronary Artery in Systole from View 2 
These analyses were performed blinded to the location of 
the culprit lesion responsible for the subsequent presentation 
 
   
 
with ST segment elevation myocardial infarction (1 above). 
An experienced interventional cardiologist subsequently 
identified the location of the culprit plaque and vessel. 
3.3. Statistical Analysis 
A two sample t-test was performed to compare QCAM for 
the non-culprit and culprit sections within the coronary 
arteries that contained a culprit lesion. A generalized linear 
mixed model was then used with culprit section as the 
dependent variable and QCAM as the independent variable. 
Grouping was by angiographic view and by patient. 
3.4. Ethics Approval of the Study Protocol 
This study complied with the Declaration of Helsinki. The 
human research ethics committee of Royal Prince Alfred 
Hospital approved the study. 
4. Results 
Twenty-eight patients were identified. Two hundred and 
eighty seven sections in the coronary arteries containing the 
culprit sections were identified and analyzed as shown in 
Table 1. The mean QCAM (ratio of end systolic length: end 
diastolic length) of the non-culprit sections was 103.51 
compared to 93.43 for the culprit sections. 
Table 1.  Summary statistics for QCAM by non-culprit and culprit section 
types 
Section 
Type Frequency Mean 
Standard Error 
of the Mean 
Standard 
Deviation 
Non- 
culprit  233 103.51 2.14 32.70 
Culprit 54 93.43 1.83 13.41 
 
Figure 2.  QCAM for each section for each of the two views for each 
patient. Non-culprit sections are blue (circles) and culprit sections are red 
(squares). 
The two sample t-test comparing QCAM for the 
non-culprit and culprit sections was highly statistically 
significant with a p-value of 0.0004.  The generalized linear 
mixed model with culprit section as the dependent variable 
and QCAM as the independent variable also showed a 
statistically significant result with a p-value of 0.026.  
5. Discussion  
These results demonstrate a significant association 
between QCAM and the location of a subsequent culprit 
lesion. Hypotheses regarding the mechanism of this link 
include the compression type of CAM being a mechanical 
stress on vascular tissue causing injury to the endothelium. 
This could not only allow atherogenesis but repetitive stress 
during the cardiac cycle could weaken plaques already 
formed and increase the risk of rupture [5].  
Despite the results showing a link with differing mean 
values of QCAM for culprit and non-culprit sections, Figure 
2 demonstrates that the QCAM of a number of non-culprit 
sections lie within the distribution seen for culprit sections. 
This may suggest that these non-culprit sections are under 
the same biomechanical stress due to coronary artery motion 
as the culprit sections and could be potential culprit sections 
in the future. One alternative explanation is the measurement 
error introduced by the foreshortening artifact and out of 
plane magnification error inherent in measuring a moving 
three-dimensional artery from a two dimensional image. 
Three-dimensional reconstructions of coronary arteries may 
overcome this limitation.  
There is no current direct clinical application for this 
research. Further development of this line of research does, 
however, lead to a number of conceivable future clinical 
applications. Better understanding of the biomechanical 
effects of current generation stent technologies may lead to 
stent strategies that result in lower rates of major adverse 
cardiac events.  Previous reports have shown that 
longitudinal straightening effect of stents to be a statistically 
significant predictor of major adverse cardiac events [11]. 
Modeling of a double stent versus a single stent strategy for a 
curved artery has suggested higher flexibility, more 
conformity and lower recoil [12]. Whether the effect of 
different stent strategies on QCAM in the vessel sections 
around the stented segments will result in different clinical 
outcomes is an untested hypothesis. 
Bioresorbable vascular scaffolds, which have been termed 
the ‘fourth revolution’ in interventional cardiology [13], 
have been shown to result in less coronary artery 
straightening when compared to metallic platform stents in a 
retrospective analysis of 102 patients [14]. The progressive 
disappearance of the polymeric scaffold will likely result in a 
different effect on QCAM compared to that of current 
generation stent technologies. If this generation of coronary 
devices is to be used for current stent indications and also for 
potential new indications such as the treatment of vulnerable 
plaques, as has already been reported in the literature [15], 
then their effect of treatment on coronary biomechanics, 
including QCAM, may have clinical significance. 
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6. Conclusion  
This study identifies that QCAM is a predictor of the 
location of culprit lesions responsible for subsequent ST 
segment elevation myocardial infarctions. Predicting the 
location of future culprit lesions using coronary angiography 
may allow targeted therapy to prevent future myocardial 
infarctions. 
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 Abstract 
Background  
Predicting the locations of coronary plaque rupture causing myocardial infarctions remains an 
elusive clinical need.  Coronary artery motion analysis provides a clinically accessible method 
that has shown promise in addressing this need. 
Methods 
20 patients were retrospectively identified with coronary angiography performed on at least two 
occasions: related to percutaneous coronary intervention for a non-ST segment elevation 
myocardial infarction and coronary angiography on an occasion prior to this. A quantitative index 
of coronary artery motion (defined as the ratio of the section lengths i.e. systolic section 
length/diastolic section length) was measured for coronary sections on the earliest angiogram. 
The culprit sections were subsequently identified at the time of non-STEMI and the quantitative 
index of coronary artery motion of these sections was compared to non-culprit sections.  
Results 
A one-sample t-test comparing the quantitative index of coronary artery motion for the non-culprit 
and culprit sections was statistically significant with a p-value of 0.04.   
Conclusions 
The quantitative index of coronary artery motion predicts the location of culprit lesions causing 
future non-ST segment elevation myocardial infarctions.  Predicting the location of future culprit 
lesions using coronary angiography may allow targeted therapy to prevent myocardial infarctions. 
 Introduction 
Acute myocardial infarctions are usually caused by rupture of atherosclerotic plaques. Plaques 
form in the coronary arteries as a response to injury (1). The location of plaques within the 
coronary arteries is asymmetrical (2), and their distribution is likely attributable to local 
biomechanical factors relating to fluid dynamics and wall mechanics. Coronary artery motion 
contributes to these biomechanical factors (3) and has been suggested to have an important role 
in the mechanisms of local injury (4). 
 
Qualitative evaluation of coronary artery motion for artery segments has previously shown that 
the compression type of motion correlates with the location of disease and the degree of stenosis 
within coronary artery segments (5) and is independently predictive of the location of future culprit 
lesions responsible for ST segment elevation myocardial infarctions (6, 7).  
 
These findings have been extended to a quantitative method using both multislice computed 
tomography (CT) coronary angiography and invasive coronary angiography. A significant 
correlation was found between a quantitative index of vessel centreline shortening and the 
location of coronary plaque and the degree of stenosis in patients having CT coronary 
angiography (8). The quantitative index of the compression type of coronary artery motion 
obtained from analysis of invasive coronary angiograms used in this study has previously been 
shown to be predictive of the location of future culprit lesions responsible for ST segment 
elevation myocardial infarctions (9). 
 
This study aims to see if a quantitative index of the compression type of coronary artery motion 
(QCAM) predicts the location of culprit lesions in patients who have subsequent non-ST segment 
elevation myocardial infarctions (non-STEMIs). 
Methods 
Patients 
Patients were identified using the angiography database at Liverpool hospital in Sydney with 
coronary angiography performed on at least two occasions: 
1.  Related to coronary angiography and percutaneous coronary intervention (PCI) for a non-
STEMI; and  
2.  Coronary angiography at least 6 months before this that was available for review.  
 
 Experienced interventional cardiologists performing the procedure on occasion 1 above made the 
diagnosis of non-STEMI. The diagnosis was made after evaluation of the patient’s clinical 
information, cardiac enzymes, and electrocardiograms. The diagnosis was recorded in the 
angiography database. Patients were excluded if they had previous coronary artery bypass 
surgery, stent thrombosis or in-stent or in-segment restenosis.  
Calculation of QCAM 
On the angiography performed on occasion 2 (above), the coronary arteries containing the 
subsequent culprit lesions were examined in two angiographic views using ezDICOM, a digital 
imaging and communications in medicine software program (10). Single frames were selected at 
end-diastole and end-systole. End-diastole was defined as the largest cardiac silhouette within 
the cardiac cycle close to the peak of the R-wave in the ECG (when available), and end-systole 
was defined as the smallest silhouette close to the end of the T-wave. Each artery was divided 
into sections based on unique identifying points and corresponding points were identified in both 
angiographic views.  
 
The length of each section was measured from the single frames selected at end-diastole and 
end-systole using the software program Image J version 1.47t (11), as previously described(9). 
The quantitative index of coronary artery motion (QCAM) is the ratio of the section lengths 
represented as a percentage i.e. 100*(systolic length/diastolic length). A QCAM value of 100 
represented no change in length of the section from end-diastole (ED) to end-systole (ES), with 
greater and lesser values corresponding to lengthening and shortening respectively.  
 
These analyses were performed blinded to the location of the culprit lesion responsible for the 
subsequent re-presentation with non-ST segment elevation myocardial infarction. An experienced 
interventional cardiologist subsequently identified the location of the culprit plaque and culprit 
section. 
Statistical Analysis 
A one-sample t-test was performed to compare QCAM for the non-culprit and culprit sections. 
Data analysis was performed using STATA version 10 (StataCorp LP. College Station, TX, USA). 
A p value <0.05 was considered significant. 
 
Ethics Approval of the Study Protocol 
 
 The human research ethics committee of Royal Prince Alfred Hospital approved the study 
(Protocol No X10-0159 & HREC/10/RPAH/291).  
Results 
Twenty patients were identified and analysed. The patients identified had their procedures at the 
hospital between December 1997 and October 2009. Table 1 shows patient demographics and 
culprit artery distribution. The culprit lesions causing non-STEMI were present in 9 left anterior 
descending coronary, 10 right coronary and 1 left circumflex coronary arteries. Patients 
represented with non-STEMI and had repeat angiography and PCI 198 days (6 months, 14 days) 
to 4195 days (11 years, 5 months, 26 days) after their prior angiograms. 
 
Table 1. Demographics of patient population and culprit artery distribution 
Age (years) +/- standard deviation 56 +/- 9 
Male gender (%) 80 
Culprit artery  
      Left anterior descending 9 
      Right 10 
      Left circumflex 1 
 
One hundred and eighty nine sections in the coronary arteries containing the culprit sections were 
identified and analysed as shown in Table 2. The mean QCAM across all non-culprit sections was 
98.16 (+/- 0.74 (standard error of the mean (SEM))). The mean QCAM across all culprit sections 
was 95.68 (+/-1.42 (SEM)). The one sample t-test comparing QCAM for the non-culprit and culprit 
sections was statistically significant with a p-value of 0.044.  
 
Table 2. Summary statistics for QCAM by non-culprit and culprit section types 
Section Type Frequency Mean Standard Error of the Mean Standard Deviation 
Non- culprit  149 98.16 0.74 9.04 
Culprit 40 95.68 1.42 8.96 
 
Figure 2 shows QCAM for the twenty patients grouped by non-culprit and culprit sections and 
angiographic view. Non-culprits were scattered around the mean of 98.16 while culprit lesions 
were mostly distributed under 98, demonstrating an association between culprit lesions and 
 sections that shortened during the cardiac cycle.  
 
 
Figure 2. Distribution of QCAM by non-culprit (NC) and culprit (C) sections and angiographic 
view. 
Figure 3 shows the distribution of QCAM across artery sections in the two angiographic views for 
each individual patient. Although most sections had similar QCAM values in both views, some of 
the measurements varied considerably. For example, for patient 10-section 1 measured very 
different QCAM values of 80 and 106 in the first and second angiographic views respectively.  
 Figure 3. QCAM for non-culprit (blue) and culprit (red) sections for both angiographic views for 
each individual patient. 
Discussion  
These results demonstrate a significant association between QCAM and the location of a 
subsequent culprit lesion responsible for non-STEMI. This association may be due to the 
compression type of CAM being a mechanical stress on vascular tissue causing injury to the 
endothelium. This may play a role in both atherogenesis and plaque rupture (5). It may also play 
a role in the mechanism by which unusual psychological stress, hypertension and a rise in 
catecholamine levels have been shown to be triggers for myocardial infarctions (12-16). In animal 
studies, administration of vasopressors significantly increase coronary artery motion parameters 
such as distance moved, maximum velocity, acceleration and deceleration (17). 
 
Despite the results showing a link with differing mean values of QCAM for culprit and non-culprit 
sections, Figure 2 demonstrates that the distribution of QCAM for non-culprit and culprit sections 
have considerable overlap. This suggests that non-culprit sections are under the same 
biomechanical stress due to coronary artery motion as the culprit sections and could be potential 
culprit sections in the future. An alternative explanation is that this overlap is due to measurement 
error introduced by the foreshortening artefact and out of plane magnification error inherent in 
 measuring a moving three-dimensional artery from a two dimensional image.  A method of 
measuring a quantitative index of coronary artery motion with three-dimensional reconstructions 
of coronary arteries may overcome this limitation.  
 
There is no current direct clinical application for this research. Further development of this line of 
research does, however, lead to a number of conceivable future clinical applications. Better 
understanding of the biomechanical effects of current generation stent technologies may lead to 
stent strategies that result in lower rates of major adverse cardiac events.  Previous reports have 
shown that longitudinal straightening effect of stents to be a statistically significant predictor of 
major adverse cardiac events (18). Modelling of a double stent versus a single stent strategy for a 
curved artery has suggested higher flexibility, more conformity and lower recoil (19). Whether the 
effect of different stent strategies on QCAM in the vessel sections around the stented segments 
will result in different clinical outcomes is an untested hypothesis. 
 
Bioresorbable vascular scaffolds, which have been termed the ‘fourth revolution’ in interventional 
cardiology (20), have been shown to result in less coronary artery straightening when compared 
to metallic platform stents in a retrospective analysis of 102 patients (21). The progressive 
disappearance of the polymeric scaffold will likely result in a different effect on QCAM compared 
to that of current generation stent technologies. If this generation of coronary devices is to be 
used for current stent indications and also for potential new indications such as the treatment of 
vulnerable plaques, as has already been reported in the literature (22), then their effect on 
coronary biomechanics, including QCAM, may have clinical significance. 
Conclusions  
This study identifies that QCAM correlates with the location of culprit lesions responsible for 
subsequent non-ST segment elevation myocardial infarctions. Predicting the location of future 
culprit lesions using coronary angiography may allow targeted therapy to prevent future 
myocardial infarctions. 
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Appendix 1 
The Stretch-Compression Type of Coronary Artery Movement Predicts the 
Location of Culprit Lesions Responsible for ST-Segment Elevation Myocardial 
Infarctions 
[Work completed prior to PhD enrolment] 
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Original Article
The Stretch–Compression Type of Coronary Artery
Movement Predicts the Location of Culprit
Lesions Responsible for ST-Segment Elevation
Myocardial Infarctions
Aiden J.C. O’Loughlin, FRACPa,∗ and Karen Byth, PhDb
a Department of Interventional Cardiology, 300 Pasteur Drive, Room H2103, Stanford University Medical Center,
Stanford, CA 94305, United States
b Westmead Millenium Institute, Westmead Hospital, Australia
Background: Prediction of the location of culprit lesions responsible for ST-segment elevation myocardial infarctions
may allow for prevention of these events by safe and easily deliverable local therapies.
Methods: A retrospective analysis of coronary movement was performed on coronary angiograms of patients who
subsequently represented with ST-segment elevation myocardial infarction treated by primary or rescue angioplasty at
a single institution.
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AResults: Twenty patients were identified. The stretch–compression type of coronary artery movement (CAM) was a
tatistically significant independent predictor of the segment containing the culprit lesion (odds ratio 6.10, p-value 0.005).
Conclusions: The stretch–compression type of coronary artery movement is an independent predictor of the location
f culprit lesions responsible for ST-segment elevation myocardial infarctions.
(Heart, Lung and Circulation 2007;16:265–268)
© 2007 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and
New Zealand. Published by Elsevier Inc. All rights reserved.
eywords. Coronary artery movement; ST-segment elevation myocardial infarction; Coronary artery disease; Culprit
esion
ntroduction
atterns of coronary artery movement (CAM) are asso-
ciated with the degree of stenosis within coronary
rtery segments.1 Coronary artery segments with the
tretch–compression (SC) type of movement have more
evere stenoses. The SC type of CAM may cause local
iomechanical injury. Atherosclerosis at these sites may
e a response to this injury.
Some coronary segments are at higher risk of being
he site of plaque rupture leading to cardiac events.2 The
ajority of acutemyocardial infarctions occur in the prox-
mal and mid segments of all three coronary arteries.3
CAM is due to myocardial movement. The amplitude of
AMis related to the ejection fraction at the timeof study.4
he ejection fraction may be reduced due to myocar-
ial dysfunction during ST-segment elevation myocardial
nfarction (STEMI). The pattern of CAM observed at this
eceived 15 August 2006; received in revised form 19 December
006; accepted 5 February 2007
Corresponding author. Tel.: +1 650 387 1763.
-mail address: aoloughlin@cvmed.stanford.edu
A.J.C. O’Loughlin).
time may not be representative of the CAM preceding the
event. CAMpatterns observed on angiography performed
before the STEMI will likely provide a better assessment
of CAM preceding plaque rupture.
The hypothesis of this study is that the stretch–
compression type of CAM predicts the location of culprit
lesions responsible for ST-segment elevation myocardial
infarctions.
Patients and Methods
Patients were identified using the angiography database
at Westmead public hospital with: (1) primary or rescue
percutaneous coronary intervention for an STEMI; and
(2) coronary angiography before this that was available
for review. STEMI was defined as chest pain char-
acteristic of ischaemia with ST segment elevation of
≥1mm in two contiguous limb leads or ≥2mm in two
contiguous chest leads. Patients were excluded if they
had previous coronary artery bypass surgery or acute
stent thrombosis. The patients identified had coronary
angiography at the hospital between March 1998 and
June 2005.2007 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of
ustralia and New Zealand. Published by Elsevier Inc. All rights reserved.
1443-9506/04/$30.00
doi:10.1016/j.hlc.2007.02.085
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The CAM patterns of coronary segments were assessed
retrospectively on the coronary angiography performed
before the STEMI and blinded to the location of the culprit
lesion responsible for the subsequent STEMI. The classi-
fication of coronary segments and assessment of stenosis
employed at Westmead public hospital was used.
TheCAMclassificationofKontaandBett1 wasused.This
classificationsystemhas10patternsofmovementgrouped
into three types (compression, bend, and displacement).
The patterns of CAM were then further grouped into the
SC type (the compression type in Konta and Bett’s clas-
sification) and non-SC type (the bend and displacement
types). All three coronary arteries were assessed using all
available views. In a single view, a visual comparison was
made between the coronary segment at the start and end
of systole. A single pattern of movement was assigned in
eachview.Each segmentwas thenassignedaCAMpattern
by synthesising the assignment for all available views.
Assessment of CAM was made in up to five segments
of the right coronary artery (RCA) (#1 proximal RCA, #2
mid RCA, #3 distal RCA, #4 posterior descending branch,
#5 first posterolateral branch), up to six segments of the
left main and left anterior descending coronary artery
(LAD) (#8 left main, #9 proximal LAD (defined as ending
at the first septal branch), #10 mid LAD, #11 distal LAD,
#13 first diagonal branch) and up to four segments of the
left circumflex coronary artery (LCX) (#17 proximal LCX,
Table 1. Patient Demographics
Age (years)± standard deviation 61± 11
Men (%) 80
Diabetes (%) 25
Current smoker (%) 45
Hypercholesterolaemia (%) 75
Hypertension (%) 55
Family history of coronary artery disease (%) 25
Table 2. Distribution of Stenosis by CAM Type
Stenosis Category (%) Non-SC Type
of CAM (%)
SC Type of
CAM (%)
1: Nil 65 (41) 16 (20)
2: Minor irregularities 63 (39) 33 (42)
3: Less than 50% 15 (9) 15 (19)
4: 50–75% 8 (5) 5 (6)
5: >75% 6 (4) 10 (13)
6: Complete occlusion 3 (2) 0
Total 160 79
p= 0.0004 (Mann–Whitney test).
Table 3. Counts (and Percentages) of Non-Culprit and Culprit
Segments by CAM Pattern and Stenosis Category
Type of CAM Non-Culprit
Segment (%)
Culprit
Segment (%)
Non-stretch–compression 156 (71) 4 (20)
Stretch–compression 63 (29) 16 (80)
p= 0.003 (Fisher’s exact test)
Stenosis category
1: Nil 77 (35) 4 (20)
2: Minor irregularities 89 (41) 7 (35)
3: Less than 50% 27 (12) 3 (15)
4: 50–75% 12 (11) 1 (5)
5: >75% 11 (5) 5 (25)
6: Complete occlusion 3 (1) 0
p= 0.03 (Mann–Whitney test)
ment. Groupingwas by patient. The explanatory variables
assessed were the type of CAM, category of stenosis, and
high risk segment. All statistical analyses were performed
using Stata version 8.0.
Results
Twenty patients presenting with STEMI were identified.
Two of these 20 had rescue angioplasty following failed
thrombolysis. The patient demographics are shown in
Table 1.
bsequent Culprit Lesion
95% Confidence Interval P Value
1.73–21.43 0.005
0.28–3.99 0.933
0.22–5.78 0.880
0.10–10.8 0.990
0.95–21.89 0.057
0.58–7.52 0.261#18 first obtuse marginal branch, #19 mid LCX, #20 sec-
ondobtusemarginal branch). Thepresence and severity of
stenosis on the previous angiogram had been assessed by
an experienced cardiologist at the time of the angiogram.
The degree of stenosis was estimated by visual inspection
using an ordinal scale (1: no stenosis, 2: minor irregular-
ities, 3: stenosis <50%, 4: stenosis of 50–75%, 5: stenosis
>75%, 6: complete occlusion).
High risk segments were defined as segments 1, 2, 9, 10,
17, and 19.
Statistical Analysis
Fisher’s exact test was used to test for an association
between the pattern of CAM on the previous angiogram
and the location of the culprit lesion identified at the time
of the STEMI. Mann–Whitney tests were used for associ-
ations between the location of the culprit lesions and the
category of stenosis; and the pattern of CAM and the loca-
tionof the culprit lesion.Ageneralised linearmixedmodel
was used to calculate odds ratios of a segment assessed on
the previous angiogram being the subsequent culprit seg-
Table 4. Adjusted Odds Ratios of a Segment Containing the Su
Explanatory Variable Odds Ratio
SC type of CAM 6.10
Stenosis category (compared to category 1: no stenosis)
2: Minor irregularities 1.06
3: Less than 50% 1.13
4: 50–75% 1.02
5: >75% 4.57
High risk segment 2.09
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Figure 1. Adjusted odds ratios of a segment containing the subsequent
culprit lesion.
The association between the SC type of CAMand steno-
sis was reconfirmed using data from the prior angiograms
in the 20 STEMI patients (p= 0.0004). Table 2 shows the
distribution of stenosis by CAM type.
We examined CAM in 239 coronary segments in the 20
patients. There was an association between the SC type
of CAM and the location of a subsequent culprit lesion
(p= 0.003). This is shown in Table 3 as well as the associa-
tion of stenosis and culprit segment.
The adjusted odds ratios of a segment being the cul-
prit segment for explanatory variables are shown in
Table 4 and Fig. 1. The SC type of CAM was an inde-
pendent predictor of the culprit artery segment (p= 0.005).
The odds ratio of a segment being a culprit segment
trended towards statistical significance for stenoses >75%
(p= 0.057).
Discussion
These results show, for the first time, that the stretch–
compression type of CAM is an independent predictor
of the location of the culprit lesion in patients having
an STEMI. This finding was independent of the severity
of stenosis and the segment being a high risk segment
defined by location.
The response to endothelial injury model of atheroscle-
rosis was first put forward byVirchow in 18565 and revised
b 6–8
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The lack of a clear predictive value for degree
of angiographic stenosis is consistent with previous
studies.16 Whether the SC type of CAM is a cause or
correlate of large histological plaques remains to be
elucidated.
Some of the weaknesses of this study are its small sam-
ple size and the potential observer bias in the qualitative
assessment of CAM. The small sample size resulted in
wide confidence intervals for the estimated odds ratios
of the explanatory variables. The technique relies on an
eyeball assessment. The previously well described high
risk segments3 and the association between stenosis and
the SC type of CAM1 means there may have been a ready
visual cue as to the possible location of the culprit seg-
ment. Assessment of CAM with quantitative techniques
mayaddress someof theseproblems.Anumberofpromis-
ing methods that may be applicable to the quantitation
of CAM include quantitative analysis of coronary motion
using coronary angiography data17,18 and intravascular
ultrasound.10,19,20
This study shows that theSC typeofCAMis an indepen-
dent predictor of the location of culprit lesions responsible
for STEMI. This may assist in the prevention of these
events in the futurebyprophylactic treatmentof these sites
in high risk patients with safe and easily deliverable local
therapies.
Ry Ross and Glomset in 1973. The shear stress of coro-
ary blood flow9–13,19 has been proposed as the cause of
ndothelial injury. Local biomechanical injury due to the
C type of CAM represents an alternative mechanism.
he absence of atherosclerosis from relatively immobile
rteries such as the internal mammary arteries could also
ossibly be explained by the relative absence of arterial
otion.
The physiological changes associatedwith unusual psy-
hological stress, hypertensionanda rise in catecholamine
evels14,15 have been shown to be triggers for STEMIs.
t is possible that they acutely increase the amplitude of
oronary artery motion leading to acute plaque rupture.eferences
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 Abstract 
Background 
We describe a novel quantitative index of coronary artery motion (QCAM4D) from four-dimensional 
reconstructions of invasive coronary angiography and test its association with the location of stenotic 
coronary artery disease requiring elective percutaneous coronary intervention for unstable angina 
pectoris. 
Methods 
Eleven patients were identified who were undergoing elective percutanous coronary intervention for 
untstable angina pectoris. The coronary arteries were divided into sections using readily available 
landmarks. Three-dimensional coronary recontructions of the coronary arteries were made at end-
systole and end-diastole. Sectional length and maximal percent stenosis for each section were 
calculated using IC3D software. QCAM4D was derived from the centerline lengths of the sections at 
end-systole and end-diastole. The section containing the stenosis being treated with percutaneous 
coronary intervention was recorded. 
Results 
The mean QCAM4D was not significantly different between coronary sections being treated for 
percutaneous coronary intervention (7.57%+/-5.96%) than those that were not (8.70%+/8.73%) 
(p=0.67).  
Conclusions 
QCAM4D is a novel quantitative measurement of coronary artery motion. It was not found to correlate 
with coronary artery sections being treated for percutaneous coronary intervention.  
  
Keywords: coronary artery disease. coronary motion . quantitative modeling 
  
 
 
 
 
  
Introduction 
 
Acute myocardial infarctions are most commonly caused by rupture of atherosclerotic plaques. Plaques 
form in the coronary arteries as a response to injury [1]. The location of plaques within the coronary 
arteries is asymmetrical [2], and their distribution is likely attributable to local biomechanical factors 
relating to fluid dynamics and wall mechanics. Coronary artery motion contributes to these biomechanical 
factors [3] and has been suggested to have an important role in the mechanisms of local injury [4]. 
Qualitative evaluation of coronary artery motion for artery segments has previously shown that the 
compression type of motion correlates with the location of disease and the degree of stenosis within 
coronary artery segments [5] and is independently predictive of the location of future culprit lesions 
responsible for ST segment elevation myocardial infarctions [6, 7].  
These findings have been extended to a quantitative method using both multislice computed tomography 
(CT) coronary angiography and invasive coronary angiography. A significant correlation has been 
reported for a quantitative index of vessel centreline shortening and the location of coronary plaque and 
the degree of stenosis in patients having CT coronary angiography[8]. A quantitative index of the 
compression type of coronary artery motion obtained from analysis of invasive coronary angiograms has 
previously been shown to be predictive of the location of future culprit lesions responsible for both ST 
segment [9] and non-ST segment elevation myocardial infarctions (unpublished manuscript)[10]. 
This study describes a novel quantitative index of coronary artery motion (QCAM) from four-
dimensional reconstructions of invasive coronary angiography and tests its association with the location 
of stenotic coronary artery disease in a sample of patients undergoing elective percutaneous coronary 
intervention for unstable angina. 
 
 
Methods 
Ethical approval of the study protocol 
The study was approved by the human research ethics committee of Royal Prince Alfred Hospital. 
Patients 
 Eleven patients undergoing percutaneous coronary intervention for unstable angina pectoris at 
Westmead Hospital between December 2007 and June 2010 were evaluated. Coronary angiography 
was performed at 15 frames per second on two Siemens angiography machines (Siemens Healthcare, 
Forchheim, Germany).  
Calculation of QCAM  
Three-dimensional (3D) quantitative coronary angiography was performed offline using 3D 
reconstruction software on the Leonardo workstation (IC3D, Siemens), which is derived from the 
Cardio-op B system (Paieon Medical, Rosh Ha'ayin, Israel). The contrast-filled non-tapered part of the 
guiding catheter was used to calibrate pixel size. Two orthogonal angiographic views of the target 
lesion in the ECG-gated end-diastolic and end-systolic frames were used for 3D-Quantitative 
Coronary Angiography (QCA) reconstructions. The site of minimum luminal diameter, and the 
proximal and distal coronary artery segments were manually identified on the first angiographic plane, 
and repeated in a second image. Proximal and distal planes were derived automatically, and the 
software automatically generated a 3D representation of the arterial lumen (Figure 1). 
 
  
Figure 1 
Representative three-dimensional reconstruction of vessel geometry using two orthogonal angiographic 
planes. (Top left) Coronary angiogram of right coronary artery in RAO 31 Cranial 25 view. (Top Right) 
Coronary angiogram of right coronary artery in RAO 38 Cranial 0 view. (Bottom middle) Three-dimensional 
reconstruction of vessel lumen in the LAO 46 Caudal 35 projection showing three-dimensional quantitative 
coronary artery measurements including diameter stenosis (%) and lesion length (L). Yellow cross defines 
the most severe stenosis in the artery section, ‘P' defines proximal site. 
 
 
A quantitative index of coronary artery motion derived from four-dimensional coronary angiography 
(QCAM4D) was defined as the percent shortening of centerline lengths between the time points 
 QCAM4D=100x(centerline length at end-diastole - centerline length at end-systole)/(centerline length 
at end-diastole)% .  
 
Statistical Analyses 
Statistical analyses were performed using Microsoft Excel. Numerical values are expressed as mean 
and standard deviation unless otherwise stated. p-Values <0.05 were considered statistically 
significant. The distributions of QCAM4D for sections with and without a stenosis being targeted for 
elective PCI were tested with a Student’s t-test.  
  
Results 
Clinical characteristics of the patients 
Baseline clinical characteristics of the patients are shown in Table 1.  
Table 1 Baseline Clinical Characteristics 
Characteristic (n=11) 
  
Age (years) 56.9(+/-10.3) 
Male sex, n (%) 9(82) 
 
The mean QCAM4D was not significantly different between coronary sections being treated for 
percutaneous coronary intervention (7.57%+/-5.96%) and those that were not (8.70%+/8.73%) 
(p=0.67).  
 Figure 2 shows a scatterplot of the % stenosis versus QCAM4D for artery sections being subject to 
elective PCI and those sections that were not undergoing PCI. 
 
Figure 2 
Scatterplot showing % stenosis versus QCAM4D for artery sections being treated with elective 
percutaneous coronary intervention (pink squares) and those not treated (blue diamonds) 
  
 
Discussion 
This study describes a novel quantitative index of coronary artery motion (QCAM) from four-
dimensional reconstructions of invasive coronary angiography. An association with the location of 
stenotic coronary artery disease was not found. All of the artery sections containing the sections being 
targeted for PCI demonstrated shortening by QCAM4D. This was an expected finding. The vast 
majority of the sections not being targeted for PCI showed a similar distribution of QCAM4D. This 
finding was unexpected.  
Possible explanations for the results of this study compared to the studies outlined in the introduction of 
this paper are the different population that was sampled. This study sample patients with unstable angina 
who were undergoing PCI. In contrast, the majority of previous studies showing an association between 
coronary artery motion were performed in patients with acute coronary syndromes who were undergoing 
PCI either concomitantly[6] or at some point in the future after a plaque rupture event[7, 9, 10]. The 
exceptions to this are the populations sampled in the original qualitative paper of Konta and Bett[5] and 
the previous CT coronary angiography study[8].  
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Abstract 
Background  
Coronary artery motion may contribute to the development of plaques that rupture and 
cause acute myocardial infarctions. This study evaluates the relationship between 
coronary artery motion and lesion location in patients with subsequent ST segment 
elevation myocardial infarction (STEMI). The hypothesis tested in this study is that 
segments of the arteries that shorten during the cardiac cycle (i.e. from end-diastole to 
end-systole) predict the location of lesions responsible for STEMI. Three-dimensional 
quantitative coronary analysis software (CAAS QCA 3D) was used to measure four-
dimensional quantitative coronary artery motion (QCAM4D) in different segmentss of 
the three main coronary arteries. QCAM4D is evaluated as a predictor of the location of 
culprit lesions causing subsequent STEMIs. 
Methods 
20 patients were identified who had angiography and subsequently re-presented at a later 
date and underwent further angiography for STEMI. The coronary arteries were divided 
into sections using readily available landmarks. Three-dimensional coronary 
reconstructions of the coronary arteries were made at end-diastole and end-systole. 
Sectional length and maximal percent stenosis for each section were calculated using 
CAAS QCA 3D software (Pie Medical Imaging BV, The Netherlands). QCAM4D was 
derived from the centerline lengths of the sections at diastole and systole.  
Results 
A generalized linear mixed model did not find QCAM4D to be a statistically significant 
predictor of the locations of subsequent STEMI (p=0.32). 
Conclusions 
QCAM4D was not predictive of the location of culprit lesions causing subsequent 
STEMI.   
  
Introduction 
Acute myocardial infarctions are usually caused by rupture of atherosclerotic plaques. 
Plaques form in the coronary arteries as a response to injury [1]. The location of plaques 
within the coronary arteries is asymmetrical [2], and their distribution is likely 
attributable to local biomechanical factors relating to fluid dynamics and wall mechanics. 
Coronary artery motion contributes to these biomechanical factors [3] and has been 
suggested to have an important role in the mechanisms of local injury [4]. 
 
Qualitative evaluation of coronary artery motion for artery segments has previously 
shown that the compression type of motion correlates with the location of disease and the 
degree of stenosis within coronary artery segments [5] and is independently predictive of 
the location of future culprit lesions responsible for ST segment elevation myocardial 
infarctions [6, 7].  
 
These findings have been extended to a quantitative method using both multislice 
computed tomography (CT) coronary angiography and invasive coronary angiography. A 
significant correlation was found between a quantitative index of vessel centreline 
shortening and the location of coronary plaque and the degree of stenosis in patients 
having CT coronary angiography [8]. A quantitative index of the compression type of 
coronary artery motion obtained from analysis of invasive coronary angiograms has 
previously been shown to be predictive of the location of future culprit lesions 
responsible for both ST segment elevation myocardial infarctions [9] and non-ST 
segment elevation myocardial infarctions [10]. 
 
This study tests the hypothesis that four-dimensional quantitative coronary artery motion 
(QCAM4D) predicts the location of culprit lesions in patients who have subsequent non-
ST segment elevation myocardial infarctions (non-STEMIs). 
Methods 
Patients 
Patients were identified using the angiography database at Liverpool public hospital. The 
  
patients had: 1. coronary intervention for a STEMI; and 2. coronary angiography before 
this that was available for review (initial coronary angiography). Classification as STEMI 
in the database was undertaken at the time of the angiogram under the guidance of the 
attending interventional cardiologist. Patients were excluded if they had previous 
coronary artery bypass surgery, stent thrombosis or in-stent or in-segment restenosis. The 
patients identified had coronary angiography at the hospital between December 1997 and 
November 2007. They re-presented with their culprit requiring PCI 372 days to 4195 
days (11 years 5 months) later. 
Calculation of QCAM4D 
Figure 1 shows an example of a patient’s angiogram before and after STEMI. In this case, 
the culprit lesion was in the proximal segment of the right coronary artery (RCA). The 
patient’s angiograms before STEMI were analysed using the CAAS QCA 3D software 
(Pie Medical Imaging BV, The Netherlands). The three main arteries (the left anterior 
descending (LAD), left circumflex (LCX) and right coronary arteries (RCA)) were 
available for analysis in all the patients. Only the artery that further developed the infarct 
lesion was assessed, with the researcher blinded to the lesion location within the artery. 
The arteries were divided into sections according to distance from the origin. Up to 6 
sections were identified in each of the 3 main arteries. 3D reconstructions of each section 
were made using CAAS QCA 3D by combining two different angiographic projections. 
The program was used to physically mark the boundaries of the section to be measured in 
both angiographic planes. The software then reconstructed a 3D image of the section and 
provided length and diameter measurements. Figure 2 demonstrates the use of CAAS 
QCA 3D to reconstruct a coronary artery section in 3D by using 2 angiographic views. 
Wang et al.’s “Standardized projections used for the coronary artery segments” (69) 
(Figure 3) guided the angiographic planes used in the formation of the 3D 
reconstructions. Sections were labelled by their location along the coronary artery, for 
example, proximal, mid and distal LAD.  
 
  
Figure 1 Initial coronary angiogram (left) and subsequent STEMI angiogram 
(right) for one patient. The culprit is evident in the proximal section of the RCA in 
the STEMI angiogram (right). 
Figure 2 Demonstration of 3D reconstruction (right) of a coronary artery section 
from 2 angiographic views (only 1 view is shown here on the left) using CAAS 
QCA 3D.  
 
  
 
Figure 3 Standardized projections used for coronary artery segments. Reproduced from 
Wang et al. (69). 
The length of each section was measured in end-diastole and end-systole and the 
percentage change in length was calculated. This was termed “percent stretch-
compression” (%SC). The largest percent stenosis (%stenosis) in each section was 
calculated from diameter measurements. The section that contained the culprit lesion was 
then identified through the follow-up angiogram and correlated with %SC and %stenosis. 
The culprit lesion and section was identified by an experienced interventional cardiologist 
on the angiogram performed following subsequent presentation with ST segment 
elevation myocardial infarction. 
Statistical Analysis 
A generalized linear mixed model was used to test for an association between the %SC 
  
measured for the section of the artery on the initial coronary angiogram and the location 
of the culprit section identified at the time of the STEMI. Grouping was by patient. The 
explanatory variables for each artery section were the percent stretch-compression (%SC) 
and the percent stenosis (%stenosis). Data analysis was performed using STATA version 
10 (StataCorp LP. College Station, TX, USA). A p value <0.05 was considered 
significant.  
 
Ethics Approval of the Study Protocol 
 
The human research ethics committee of Royal Prince Alfred Hospital approved the 
study (Protocol No X10-0159 & HREC/10/RPAH/291). The ethics committee approved 
performance of the study without direct patient consent. The ethics committee agreed that 
it was impractical to obtain consent from patients after considering that procedures 
occurred up to 17 years previously, that patients may be deceased or difficult to locate, 
the absence of direct patient contact in the protocol, and the security measures used to 
protect the privacy of the patients. 
Results 
Twenty patients were identified and analysed. Table 1 shows patient demographics and 
culprit artery distribution. The culprit lesions were present in 11 LAD, 8 RCA and 1 LCx 
arteries. 102 sections were analyzed across all arteries. 
 
Table 1 Patient demographics and culprit artery distribution for STEMI group 
Age (years) +/- standard deviation 57 +/- 1 
Male gender (%) 75 
Culprit artery  
Left anterior descending 11 
Right coronary artery 8 
Left circumflex 1 
  
  
Table 2 shows the association between %SC, %stenosis and culprit section for STEMI. 
No significant relationship was identified between %SC and culprit section (P=0.32). The 
relationship between %stenosis and culprit lesion location was not statistical significant 
(P=0.09). 
 
Table 2 Generalized linear mixed statistical analysis showing relationship between %SC 
and %stenosis and culprit lesion location 
Culprit	   Coef	   StdErr	   z	   P-­‐value	   [95%	  Conf.	  Interval]	  
%	  SC	   0.03	   0.03	   -­‐1.00	   0.32	   -­‐0.08	   0.03	  
%	  Stenosis	   0.05	   0.03	   1.68	   0.09	   -­‐0.01	   0.11	  
Constant	   0.22	   2.74	   0.08	   0.94	   -­‐5.15	   5.59	  
 
  
  
Figure 4 plots %SC for each section of the culprit arteries. A %SC value of 100 
represented no change in length of the section from end-diastole (ED) to end-
systole (ES), with variations above and below this value corresponding to 
lengthening and shortening respectively.  
 
Figure 4 Scatter plot arranged by patient number, demonstrating %SC for each coronary 
artery section. NC, non-culprit sections; C, culprit sections 
%SC varied greatly throughout culprit and non-culprit lesions. The majority of 
culprit lesions had %SC values near 100 (e.g. patients 1-5) and below 100 (e.g. 
patient 12 & 16), while a small number had %SC above 100 (e.g. patient 14 &19). 
  
  
Figure 5 compares the distribution of non-culprit and culprit lesions across %SC. 
Non-culprit lesions were mainly scattered around the 100%SC value while culprit 
lesions were mostly distributed under 100%SC. However, this relationship did not 
reach statistical significance in our analysis (P=0.32).  
	  
Figure 5 Distribution of %SC for culprit (C) and non-culprit (NC) sections.	  
  
  
Figure 6 groups the culprit and non-culprit sections by section number. Culprit 
lesions tended to cluster in the proximal and mid sections of the LAD and RCA. 
Only one LCx was analyzed, and the culprit lesion was in the mid section. 
 
Figure 6 Distribution of non-culprit (NC) and culprit (C) sections across %SC. Grouping 
is by section number: 1, proximal RCA; 2, mid RCA; 3, distal RCA; 4, posterior 
descending artery; 9, proximal LAD; 10, mid LAD; 11, distal LAD; 16, proximal LCx; 
17, mid LCx; 18, distal LCx. 
  
  
Discussion  
This study describes a novel quantitative index of coronary artery motion (QCAM4D) 
from four-dimensional reconstructions of invasive coronary angiography. QCAM4D 
did not predict the location of subsequent STEMI (p=0.32). 
The result of this study was unexpected. Previous published studies performed in 
patients with acute coronary syndromes who were undergoing PCI either 
concomitantly[6] or at some point in the future after a plaque rupture event[7, 9, 10] 
have shown an association between the type of coronary artery motion underpinning 
QCAM4D and the location of culprit plaque rupture. Use of QCAM4D in this research 
was performed to reduce the measurement error of the methods used in these previous 
reports that were performed using 2-dimensional images from coronary angiography.  
The foreshortening artefact and out of plane magnification error inherent in measuring 
a moving three-dimensional artery from a two-dimensional image was hoped to be 
reduced by the three-dimensional reconstructions of coronary arteries used in the 
calculation of QCAM4D. The accuracy of the measurements of QCAM4D using the 
software and method described in this paper remains untested and requires validation 
before firm conclusions are made about the results presented in this paper. 
Improved prediction of clinical events from coronary artery disease remains a 
compelling clinical need. Whether analysis of coronary artery motion has a role to 
play in meeting this clinical need requires further evaluation. 
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